KR102502664B1 - Cosmetic composition for improving skin and hair condition containing Solanum Lycopersicum(Tomato) Fruit exosome, Brassica Oleracea Italica(Broccoli) exosome - Google Patents
Cosmetic composition for improving skin and hair condition containing Solanum Lycopersicum(Tomato) Fruit exosome, Brassica Oleracea Italica(Broccoli) exosome Download PDFInfo
- Publication number
- KR102502664B1 KR102502664B1 KR1020220121020A KR20220121020A KR102502664B1 KR 102502664 B1 KR102502664 B1 KR 102502664B1 KR 1020220121020 A KR1020220121020 A KR 1020220121020A KR 20220121020 A KR20220121020 A KR 20220121020A KR 102502664 B1 KR102502664 B1 KR 102502664B1
- Authority
- KR
- South Korea
- Prior art keywords
- broccoli
- exosomes
- tomato
- hours
- cosmetic composition
- Prior art date
Links
- 210000001808 exosome Anatomy 0.000 title claims abstract description 192
- 235000007688 Lycopersicon esculentum Nutrition 0.000 title claims abstract description 160
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 title claims abstract description 152
- 235000017647 Brassica oleracea var italica Nutrition 0.000 title claims abstract description 151
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- 239000002537 cosmetic Substances 0.000 title claims abstract description 32
- 240000003768 Solanum lycopersicum Species 0.000 title claims description 158
- 210000004209 hair Anatomy 0.000 title abstract description 30
- 241000227653 Lycopersicon Species 0.000 title abstract 3
- 244000308180 Brassica oleracea var. italica Species 0.000 title description 15
- 235000013399 edible fruits Nutrition 0.000 title description 4
- 235000002560 Solanum lycopersicum Nutrition 0.000 title 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims abstract description 139
- 238000007602 hot air drying Methods 0.000 claims abstract description 33
- 230000002087 whitening effect Effects 0.000 claims abstract description 18
- 230000003779 hair growth Effects 0.000 claims abstract description 14
- 239000004480 active ingredient Substances 0.000 claims abstract description 11
- 230000003658 preventing hair loss Effects 0.000 claims abstract description 10
- 239000006228 supernatant Substances 0.000 claims description 21
- 239000002202 Polyethylene glycol Substances 0.000 claims description 18
- 229920001223 polyethylene glycol Polymers 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 17
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 229920002307 Dextran Polymers 0.000 claims description 12
- 238000004108 freeze drying Methods 0.000 claims description 8
- 230000001737 promoting effect Effects 0.000 claims description 8
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 35
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 239000000284 extract Substances 0.000 description 48
- 238000012360 testing method Methods 0.000 description 36
- 210000004027 cell Anatomy 0.000 description 28
- 230000005764 inhibitory process Effects 0.000 description 28
- 210000003491 skin Anatomy 0.000 description 27
- 238000009472 formulation Methods 0.000 description 20
- 239000002245 particle Substances 0.000 description 18
- 241000196324 Embryophyta Species 0.000 description 17
- 238000004458 analytical method Methods 0.000 description 17
- 230000000052 comparative effect Effects 0.000 description 16
- 239000000243 solution Substances 0.000 description 13
- 230000001965 increasing effect Effects 0.000 description 11
- 102000003425 Tyrosinase Human genes 0.000 description 10
- 108060008724 Tyrosinase Proteins 0.000 description 10
- 239000006071 cream Substances 0.000 description 10
- 230000002500 effect on skin Effects 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 9
- 230000014509 gene expression Effects 0.000 description 9
- 201000004384 Alopecia Diseases 0.000 description 8
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 7
- 108010002352 Interleukin-1 Proteins 0.000 description 7
- 108090001005 Interleukin-6 Proteins 0.000 description 7
- 230000003676 hair loss Effects 0.000 description 7
- 208000024963 hair loss Diseases 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 230000028327 secretion Effects 0.000 description 7
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 6
- 206010015150 Erythema Diseases 0.000 description 6
- 102000000589 Interleukin-1 Human genes 0.000 description 6
- 102000004889 Interleukin-6 Human genes 0.000 description 6
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 6
- 230000004663 cell proliferation Effects 0.000 description 6
- 230000001419 dependent effect Effects 0.000 description 6
- 231100000321 erythema Toxicity 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 230000008099 melanin synthesis Effects 0.000 description 6
- 108020004999 messenger RNA Proteins 0.000 description 6
- 239000013642 negative control Substances 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 238000004627 transmission electron microscopy Methods 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 235000015193 tomato juice Nutrition 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- DAYLJWODMCOQEW-TURQNECASA-N NMN zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)([O-])=O)O2)O)=C1 DAYLJWODMCOQEW-TURQNECASA-N 0.000 description 4
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 4
- 229960003473 androstanolone Drugs 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 231100000135 cytotoxicity Toxicity 0.000 description 4
- 230000003013 cytotoxicity Effects 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000002105 nanoparticle Substances 0.000 description 4
- 150000003904 phospholipids Chemical class 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- SUVMJBTUFCVSAD-UHFFFAOYSA-N sulforaphane Chemical compound CS(=O)CCCCN=C=S SUVMJBTUFCVSAD-UHFFFAOYSA-N 0.000 description 4
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 3
- 240000007124 Brassica oleracea Species 0.000 description 3
- 231100000002 MTT assay Toxicity 0.000 description 3
- 238000000134 MTT assay Methods 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229960000458 allantoin Drugs 0.000 description 3
- 230000003656 anti-hair-loss Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000003780 hair follicle Anatomy 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 3
- 229960004441 tyrosine Drugs 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- SUVMJBTUFCVSAD-JTQLQIEISA-N 4-Methylsulfinylbutyl isothiocyanate Natural products C[S@](=O)CCCCN=C=S SUVMJBTUFCVSAD-JTQLQIEISA-N 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 2
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 2
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 2
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 241000208292 Solanaceae Species 0.000 description 2
- 238000003917 TEM image Methods 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- 239000003098 androgen Substances 0.000 description 2
- 229940030486 androgens Drugs 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000003700 hair damage Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 231100001231 less toxic Toxicity 0.000 description 2
- 235000012680 lutein Nutrition 0.000 description 2
- 239000001656 lutein Substances 0.000 description 2
- 229960005375 lutein Drugs 0.000 description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 2
- 235000012661 lycopene Nutrition 0.000 description 2
- 239000001751 lycopene Substances 0.000 description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 2
- 229960004999 lycopene Drugs 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229960003632 minoxidil Drugs 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000012089 stop solution Substances 0.000 description 2
- 229960005559 sulforaphane Drugs 0.000 description 2
- 235000015487 sulforaphane Nutrition 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229960003604 testosterone Drugs 0.000 description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000011303 Brassica alboglabra Nutrition 0.000 description 1
- 235000011302 Brassica oleracea Nutrition 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 101100000858 Caenorhabditis elegans act-3 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- RUQCCAGSFPUGSZ-OBWQKADXSA-N Glucoraphanin Natural products C[S@](=O)CCCCC(=NS(=O)(=O)O)S[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RUQCCAGSFPUGSZ-OBWQKADXSA-N 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 238000010818 SYBR green PCR Master Mix Methods 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 102000011990 Sirtuin Human genes 0.000 description 1
- 108050002485 Sirtuin Proteins 0.000 description 1
- 235000002634 Solanum Nutrition 0.000 description 1
- 241000207763 Solanum Species 0.000 description 1
- 235000003953 Solanum lycopersicum var cerasiforme Nutrition 0.000 description 1
- 240000003040 Solanum lycopersicum var. cerasiforme Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- GMMLNKINDDUDCF-JRWRFYLSSA-N [(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1e)-5-[(r)-methylsulfinyl]-n-sulfooxypentanimidothioate Chemical compound C[S@@](=O)CCCC\C(=N/OS(O)(=O)=O)S[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GMMLNKINDDUDCF-JRWRFYLSSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- RXVGBQCEAQZMLW-UHFFFAOYSA-N alpha-solanine Natural products CC1CCC2C(C)C3C(CC4C5CC=C6CC(CCC6(C)C5CCC34C)OC7OC(CO)C(O)C(OC8OC(CO)C(O)C(O)C8O)C7OC9OC(CO)C(O)C(O)C9O)N2C1 RXVGBQCEAQZMLW-UHFFFAOYSA-N 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000007698 birth defect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000009087 cell motility Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229960004039 finasteride Drugs 0.000 description 1
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000021384 green leafy vegetables Nutrition 0.000 description 1
- 210000002768 hair cell Anatomy 0.000 description 1
- -1 hair pack Substances 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- ZGVSETXHNHBTRK-OTYSSXIJSA-N solanine Chemical compound O([C@H]1[C@@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@@H]5N6C[C@@H](C)CC[C@@H]6[C@H]([C@@H]5[C@@]4(C)CC[C@@H]3[C@@]2(C)CC1)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ZGVSETXHNHBTRK-OTYSSXIJSA-N 0.000 description 1
- 229940031352 solanine Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/81—Preparation or application process involves irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 토마토, 브로콜리 유래 엑소좀을 유효성분으로 함유하는 피부 및 모발 상태개선용 화장료 조성물에 관한 것으로, 구체적으로는 열풍건조와 UV 전처리 및 수성 2상 시스템을 이용하여 정제된 토마토 엑소좀 및/또는 브로콜리 엑소좀을 유효성분으로 함유하여 미백, 항염, 피부 진정효과와 모발 성장 촉진, 탈모 방지 효과가 우수한 피부 및 모발 상태개선용 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition for improving skin and hair conditions containing tomato and broccoli-derived exosomes as an active ingredient, and specifically, tomato exosomes purified using hot air drying, UV pretreatment, and an aqueous two-phase system and/or Or, it relates to a cosmetic composition for improving skin and hair conditions containing broccoli exosomes as an active ingredient and having excellent whitening, anti-inflammatory, skin soothing effects, hair growth promotion, and hair loss prevention effects.
화장품의 기능은 청결과 단순한 메이크업을 지나, 공해 물질, 스트레스, 자외선, 활성산소, 과산화물 등의 피부 노화 원인을 제거하거나 억제하는 것으로 확장되어 왔다. 최근 들어 안전한 천연물을 소재로 하여 피부 주름을 개선하고, 피부 자극 및 염증을 완화시켜 주는 화장료의 개발이 활발하게 이루어지고 있다. 또한 현대사회에서는 모발 손상이나 탈모에 시달리는 사람들이 늘어나고 있으며 탈모증을 치료하기 위해 가발, 모이식 수술과 같은 외곽적인 시술이나 약물 치료와 같이 탈모증을 치료하기 위해 다양한 시도가 이루어지고 있다. 탈모의 원인은 유전적 원인, 모발 세포 기능 저하, 남성호르몬의 과잉 분비, 피지의 과잉 분비 등이 있으며 주로 남성호르몬인 안드로겐(androgen)이 중요한 인자로 작용되고 있다. 안드로겐 중 테스토스테론(testosterone)은 모낭에 도달하면 5알파-환원효소에 의해 디하이드로테스토스테론(dihydrotestosterone:DHT)으로 전환이 되고 이 호르몬은 모낭을 위축시키고 모발을 서서히 가늘게 만드는 성질이 있어 탈모를 일으킨다.The function of cosmetics has expanded beyond cleanliness and simple makeup to removing or suppressing causes of skin aging such as pollutants, stress, ultraviolet rays, active oxygen, and peroxide. Recently, the development of cosmetics for improving skin wrinkles and alleviating skin irritation and inflammation using safe natural materials as materials has been actively conducted. In addition, in modern society, the number of people suffering from hair damage or hair loss is increasing, and various attempts are being made to treat hair loss, such as external procedures such as wigs and transplant surgery, or drug treatment. The causes of hair loss include genetic causes, deterioration in hair cell function, excessive secretion of male hormones, and excessive secretion of sebum, and androgens, which are mainly male hormones, act as an important factor. Testosterone among androgens is converted to dihydrotestosterone (DHT) by 5-alpha-reductase when it reaches the hair follicle.
이러한 탈모증의 치료에는 미녹시딜(minoxidil), 피나스트라이드(finasteride)를 함유한 제제가 대표적이지만 성기능장애, 기형아 출산 가능성, 저혈압, 빈맥, 심혈 관계 합병증과 같은 부작용이 발생함에 따라 사용에 많은 제약이 있다. 따라서 부작용이 없는 천연 소재를 이용한 발모제 및 헤어 관련 제품에 대한 연구가 활발하게 진행되고 있다.For the treatment of such alopecia, preparations containing minoxidil and finasteride are representative, but there are many limitations in their use due to side effects such as sexual dysfunction, possibility of birth defects, hypotension, tachycardia, and cardiovascular complications. Therefore, studies on hair growth agents and hair-related products using natural materials without side effects are being actively conducted.
본 발명에서 "엑소좀(Exosome)"이란 다양한 세포들로부터 분비되는 막 구조의 작은 소낭을 의미하며, 세포밖 소포체(Extracellular Vesicles, EVs)의 한 종류로 정의된다. 모든 세포들은 다른 세포들 또는 외부 환경과 정보 교환을 하며 이를 위해 세포밖 소포체를 분비한다. 엑소좀은 50~200 nm 정도의 크기를 가지며 단백질, 지질, 핵산 등 생리활성 물질을 포함한다. 엑소좀은 포유류, 박테리아, 식물 등 다양한 세포에 존재하며 기원하는 세포들의 상태를 반영하고 있어 진단 및 치료에 활용할 수 있다. 엑소좀은 이중인지질막 구조체로 세포내 침투가 용이하고, 면역 반응, 신호전달과 같은 다양한 생리적, 병리적 기능을 수행한다. In the present invention, "Exosome" means a small membrane-structured vesicle secreted from various cells, and is defined as a type of extracellular vesicles (EVs). All cells exchange information with other cells or the external environment and secrete extracellular endoplasmic reticulum for this purpose. Exosomes have a size of about 50 to 200 nm and contain physiologically active substances such as proteins, lipids, and nucleic acids. Exosomes exist in various cells such as mammals, bacteria, and plants, and can be used for diagnosis and treatment because they reflect the state of the originating cells. Exosomes are a double-phospholipid membrane structure that is easily penetrated into cells and performs various physiological and pathological functions such as immune response and signal transduction.
최근에 식물에서 유래한 엑소좀의 다양한 효능에 관한 연구가 이루어지고 있으며 이의 미백, 항염 등의 피부 효능에 대해서도 연구가 시작되고 있다. 식물 유래 엑소좀은 식물 세포 자체가 분비하는 생리활성 및 신호전달물질이 들어있어 세포간의 이동과 흡수에 도움을 주는 천연 나노입자이며, 식물에서 정제한 엑소좀은 포유류 유래 엑소좀에 비해 독성이 없다고 알려져 있다. Recently, studies on the various effects of plant-derived exosomes have been conducted, and studies on skin effects such as whitening and anti-inflammatory have also begun. Plant-derived exosomes are natural nanoparticles that help cell movement and absorption as they contain physiological activity and signaling substances secreted by plant cells themselves, and exosomes purified from plants are less toxic than mammalian-derived exosomes. It is known.
이러한 엑소좀은 다양한 장점 및 활성으로 인해 의약품, 화장품, 식품 등의 분야에서 활용이 가능한 소재이나 인지질이중막으로 구성되어 있는 구조적인 특징으로 인해 분산력이 낮고 응집하려는 성질이 있다. 또한 고온에서 불안정하고, 화장품 제형을 제조하는 과정에서 쉽게 깨질 수 있으며, 이러한 성질은 제형 내 엑소좀의 안정성을 저하시키고 침전을 일으킬 수 있다. 따라서 지속적인 활성 유지를 위해 수용액 내의 엑소좀의 용해도 및 분산성을 높여 제형 내 안정성을 높일 필요가 있다.These exosomes are materials that can be used in the fields of medicine, cosmetics, food, etc. due to their various advantages and activities, but have low dispersibility and tend to aggregate due to their structural characteristics consisting of a phospholipid bilayer. In addition, it is unstable at high temperatures and can be easily broken in the process of preparing cosmetic formulations, and these properties may reduce the stability of exosomes in formulations and cause precipitation. Therefore, it is necessary to increase the stability in the formulation by increasing the solubility and dispersibility of exosomes in an aqueous solution in order to maintain continuous activity.
본 발명자들은 다양한 방법을 적용하여 우수한 피부 및 모발 상태개선 활성을 나타내는 식물 유래 엑소좀을 제조하고 이를 화장료로 이용하기 위해 노력하였으며, 그 결과 특정한 조건에서의 열풍건조, UV 전처리와 수성 2상 시스템을 이용하여 정제된 토마토 엑소좀 및/또는 브로콜리 엑소좀이 우수한 피부 및 모발 상태개선 효과를 나타낸다는 것을 확인하여 본 발명을 완성하였다.The present inventors applied various methods to prepare plant-derived exosomes exhibiting excellent skin and hair condition improvement activity and tried to use them as cosmetics. As a result, hot air drying under specific conditions, UV pretreatment, and an aqueous two-phase system The present invention was completed by confirming that the purified tomato exosomes and/or broccoli exosomes exhibited excellent skin and hair condition improvement effects.
본 발명은 토마토 엑소좀, 브로콜리 엑소좀 또는 그 혼합 엑소좀을 유효성분으로 함유하여 안정성이 우수하며 미백, 항염, 피부진정 효과, 모발 성장 촉진 및 탈모 방지 효과가 우수한 피부 및 모발 상태개선용 화장료 조성물을 제공하는 것을 목적으로 한다.The present invention contains tomato exosomes, broccoli exosomes, or mixed exosomes as active ingredients and has excellent stability, whitening, anti-inflammatory, skin soothing effects, hair growth promotion and hair loss prevention cosmetic composition for improving skin and hair conditions is intended to provide
또한, 본 발명은 토마토 엑소좀 또는 브로콜리 엑소좀의 정제방법을 제공하는 것을 다른 목적으로 한다.Another object of the present invention is to provide a method for purifying tomato exosomes or broccoli exosomes.
상기 목적을 달성하기 위하여 본 발명에 따르면, 토마토 엑소좀, 브로콜리 엑소좀 또는 그 혼합 엑소좀을 유효성분으로 함유하는 화장료 조성물이 제공된다.In order to achieve the above object, according to the present invention, a cosmetic composition containing tomato exosomes, broccoli exosomes, or mixed exosomes as an active ingredient is provided.
상기 유효성분으로서의 토마토 엑소좀과 브로콜리 엑소좀은,Tomato exosomes and broccoli exosomes as the active ingredient,
(A) 토마토 또는 브로콜리를 40~60℃, 20~24시간 열풍건조 처리하는 단계; (B) 열풍건조 처리한 토마토 또는 브로콜리를 30~40℃의 물에 6시간동안 침지하는 단계; (C) 침지시킨 토마토 또는 브로콜리에 UV-A를 1~6시간 처리하는 단계; (D) UV 처리한 토마토 또는 브로콜리를 착즙하는 단계; (E)상기 착즙액을 1,000xg~10,000xg에서 원심분리하여 상층액을 수득하는 단계; (F)엑소좀이 존재하는 상기 상층액을 동결건조하는 단계; (G)상기 동결건조물에 PEG(Polyethylene glycol)/Dextran을 사용하여 수성 2상계를 형성하는 단계; 및 (H)상기 수성 2상계 중 엑소좀이 농축된 하층액을 수득하는 단계를 포함하는 방법에 의하여 정제된 것이다.(A) subjecting tomatoes or broccoli to hot air drying at 40 to 60° C. for 20 to 24 hours; (B) immersing tomatoes or broccoli treated with hot air drying in water at 30 to 40 ° C. for 6 hours; (C) UV-A treatment of immersed tomatoes or broccoli for 1 to 6 hours; (D) squeezing UV-treated tomatoes or broccoli; (E) obtaining a supernatant by centrifuging the juice at 1,000xg to 10,000xg; (F) freeze-drying the supernatant in which exosomes are present; (G) forming an aqueous two-phase system using PEG (Polyethylene glycol)/Dextran in the lyophilisate; and (H) obtaining an exosome-enriched lower layer in the aqueous two-phase system.
더욱 바람직하게는 상기 (A) 단계에서의 열풍건조 처리는 50℃의 온도에서 24시간 동안 수행하며 (C) 단계에서의 UV 처리는 365nm 파장의 UV-A로 6시간 동안 수행한다.More preferably, the hot air drying treatment in step (A) is performed at a temperature of 50 ° C. for 24 hours, and the UV treatment in step (C) is performed with UV-A at a wavelength of 365 nm for 6 hours.
유효성분으로서의 상기 토마토 엑소좀, 브로콜리 엑소좀 또는 그 혼합 엑소좀은 조성물 전체중량에 대하여 0.0001 ~ 30.0%(w/w) 함유된다.The tomato exosomes, broccoli exosomes, or mixed exosomes as active ingredients are contained in an amount of 0.0001 to 30.0% (w/w) based on the total weight of the composition.
상기 화장료 조성물은 미백용, 항염용 또는 피부진정용임을 특징으로 한다. 또한 상기 화장료 조성물은 모발 성장 촉진용 또는 탈모 방지용임을 특징으로 한다.The cosmetic composition is characterized in that it is for whitening, anti-inflammatory or skin soothing. In addition, the cosmetic composition is characterized in that for promoting hair growth or preventing hair loss.
상기 다른 목적을 달성하기 위하여 본 발명에 따르면, According to the present invention in order to achieve the above other object,
(A)토마토 또는 브로콜리를 40~60℃, 20~24시간 열풍건조 처리하는 단계; (A) subjecting tomatoes or broccoli to hot air drying at 40 to 60° C. for 20 to 24 hours;
(B)열풍건조 처리한 토마토 또는 브로콜리를 30~40℃의 물에 침지하는 단계; (B) immersing tomatoes or broccoli treated with hot air drying in water at 30 to 40 ° C;
(C)침지시킨 토마토 또는 브로콜리에 UV-A를 1~6시간 처리하는 단계; (C) UV-A treatment of immersed tomatoes or broccoli for 1 to 6 hours;
(D)UV 처리한 토마토 또는 브로콜리를 착즙하는 단계;(D) squeezing UV-treated tomatoes or broccoli;
(E)상기 착즙액을 1,000xg~10,000xg에서 원심분리하여 상층액을 수득하는 단계; (E) obtaining a supernatant by centrifuging the juice at 1,000xg to 10,000xg;
(F)엑소좀이 존재하는 상기 상층액을 동결건조하는 단계; (F) freeze-drying the supernatant in which exosomes are present;
(G)상기 동결건조물에 PEG(Polyethylene glycol)/Dextran을 사용하여 수성 2상계를 형성하는 단계; 및 (G) forming an aqueous two-phase system using PEG (Polyethylene glycol)/Dextran in the lyophilisate; and
(H)상기 수성 2상계 중 엑소좀이 농축된 하층액을 수득하는 단계를 포함하는 토마토 또는 브로콜리 엑소좀의 정제방법이 제공된다.(H) There is provided a method for purifying tomato or broccoli exosomes comprising the step of obtaining a lower layer in which exosomes are concentrated in the aqueous two-phase system.
상기 (A) 단계에서의 열풍건조 처리는 50℃의 온도에서 24시간 동안 수행하며 (C) 단계에서의 UV 처리는 365nm 파장의 UV-A로 6시간 동안 수행하는 것임을 특징으로 한다.The hot air drying treatment in step (A) is performed at a temperature of 50 ° C. for 24 hours, and the UV treatment in step (C) is performed for 6 hours with UV-A at a wavelength of 365 nm.
열풍건조 및 UV 전처리와 수성 2상 시스템을 이용하여 정제된 본 발명의 토마토 엑소좀, 브로콜리 엑소좀 또는 그 혼합 엑소좀은 안정성이 우수하며, 우수한 미백 효과, 항염 효과, 피부진정 효과 및 모발 성장 촉진 효과와 탈모 방지 효과를 나타내므로 피부 및 모발 상태개선용 화장료로 유용하게 사용될 수 있다.Tomato exosomes, broccoli exosomes, or mixed exosomes of the present invention purified using hot air drying, UV pretreatment, and an aqueous two-phase system have excellent stability, excellent whitening effect, anti-inflammatory effect, skin soothing effect, and hair growth promotion It can be usefully used as a cosmetic for improving skin and hair conditions because it shows the effect of preventing hair loss and hair loss.
도 1은 본 발명의 일 실시예에 따라 정제된 토마토 유래 엑소좀의 TEM 이미지이다.
도 2는 본 발명의 일 실시예에 따라 정제된 브로콜리 유래 엑소좀의 TEM 이미지이다.
도 3은 본 발명의 일 실시예에 따라 정제된 토마토 유래 엑소좀 입자의 크기 분포와 입자수를 확인하기 위한 NTA 분석 결과를 나타낸 그래프이다.
도 4는 본 발명의 일 실시예에 따라 정제된 브로콜리 유래 엑소좀 입자의 크기 분포와 입자수를 확인하기 위한 NTA 분석 결과를 나타낸 그래프이다.
도 5는 본 발명에 의해 정제된 토마토, 브로콜리 유래 엑소좀의 세포 독성을 MTT assay로 평가한 결과를 나타낸 그래프이다.
도 6은 본 발명에 의해 정제된 토마토, 브로콜리 유래 엑소좀의 미백 효능을 티로시나아제 활성 억제율로 평가한 결과를 나타낸 그래프이다.
도 7은 본 발명에 의해 정제된 토마토, 브로콜리 유래 엑소좀의 미백 효능을 멜라닌 생성 억제율로 평가한 결과를 나타낸 그래프이다.
도 8은 본 발명에 의해 정제된 토마토, 브로콜리 유래 엑소좀의 항염 효능을 IL-1 발현 억제율로 평가한 결과를 나타낸 그래프이다.
도 9는 본 발명에 의해 정제된 토마토, 브로콜리 유래 엑소좀의 항염 효능을 IL-6 발현 억제율로 평가한 결과를 나타낸 그래프이다.
도 10은 본 발명에 의해 정제된 토마토, 브로콜리 유래 엑소좀의 모발 성장 촉진 효과를 모유두세포 증식 효과로 평가한 결과를 나타낸 그래프이다.
도 11은 본 발명에 의해 정제된 토마토, 브로콜리 유래 엑소좀의 탈모 방지 효능을 5알파-환원효소 저해 활성시험으로 평가한 결과를 나타낸 그래프이다. 1 is a TEM image of tomato-derived exosomes purified according to an embodiment of the present invention.
2 is a TEM image of purified broccoli-derived exosomes according to an embodiment of the present invention.
Figure 3 is a graph showing the NTA analysis results for confirming the size distribution and particle number of purified tomato-derived exosome particles according to an embodiment of the present invention.
Figure 4 is a graph showing the NTA analysis results for confirming the size distribution and particle number of purified broccoli-derived exosome particles according to an embodiment of the present invention.
5 is a graph showing the results of evaluating the cytotoxicity of exosomes derived from tomato and broccoli purified according to the present invention by MTT assay.
6 is a graph showing the results obtained by evaluating the whitening efficacy of tomato and broccoli-derived exosomes purified according to the present invention in terms of tyrosinase activity inhibition rate.
7 is a graph showing the results obtained by evaluating the whitening efficacy of tomato and broccoli-derived exosomes purified according to the present invention in terms of melanin production inhibition rate.
8 is a graph showing the results obtained by evaluating the anti-inflammatory efficacy of tomato and broccoli-derived exosomes purified according to the present invention in terms of IL-1 expression inhibition rate.
9 is a graph showing the results obtained by evaluating the anti-inflammatory efficacy of tomato and broccoli-derived exosomes purified according to the present invention in terms of IL-6 expression inhibition rate.
10 is a graph showing the results of evaluating the hair growth promoting effect of exosomes derived from tomato and broccoli purified according to the present invention as the dermal papilla cell proliferation effect.
11 is a graph showing the results obtained by evaluating the anti-hair loss efficacy of tomato and broccoli-derived exosomes purified according to the present invention by a 5-alpha-reductase inhibitory activity test.
이하, 본 발명을 더욱 구체적으로 설명한다.Hereinafter, the present invention will be described in more detail.
식물 유래 엑소좀은 식물 세포 자체가 분비하는 생리활성 및 신호전달물질을 함유하고 있으며, 포유류 유래 엑소좀에 비해 독성이 없다고 알려져 있다. 이러한 장점으로 인해 의약품, 화장품, 식품 등의 분야에서 활용이 가능한 소재이나 인지질 이중막으로 구성되어 있는 구조적인 특징으로 인해 분산력이 낮고 응집하려는 성질이 있어, 제형 내에서 그 활성을 지속적으로 유지하기 어렵다는 문제점을 가진다. 본 발명은 토마토, 브로콜리로부터 엑소좀을 고순도로 분리 정제하여, 이를 피부 및 모발용 화장료로 이용하는 것을 기술적 특징으로 한다.Plant-derived exosomes contain physiological activity and signaling substances secreted by plant cells themselves, and are known to be less toxic than mammalian-derived exosomes. Due to these advantages, it is a material that can be used in the fields of medicine, cosmetics, food, etc., but due to the structural feature consisting of a phospholipid double membrane, it has low dispersibility and tends to aggregate, making it difficult to maintain its activity continuously in the formulation. have a problem The technical feature of the present invention is to separate and purify exosomes from tomatoes and broccoli with high purity and use them as cosmetics for skin and hair.
토마토(Solanum lyclpersicum)은 가지목 가지과에 속하는 식물로 열매는 식용한다. 라틴아메리카가 원산지인 한해살이풀로, 키는 1~3m에 노란색 꽃이 핀다. 열매는 라이코펜에 의해 붉은색을 띤다. 덩굴식물로 본래는 땅바닥을 기면서 줄기에서 뿌리가 나와 자라지만, 재배할 때는 세워서 재배한다. 가지과에 속하는 종들이 갖는 씨의 성분인 솔라닌이 아주 미량 들어있으니 유의하여야 한다. 토마토는 타임지에서 선정한 세계 10대 슈퍼푸드에서 선정되었으며 맛과 영양이 뛰어나 서양에서는 천국의 과일로 불리기도 한다. 찰토마토, 대저토마토, 스테비아 토마토, 방울토마토, 대추 토마토, 흑토마토 등 많이 알려져 있는 품종 외에도 약 500여종의 품종이 있다. 토마토의 성분 중 95%가 수분이고 비타민과 무기질 함량이 풍부한 알칼리성 식품으로 피부 미용에 좋고 칼로리도 낮아 다이어트 식단으로도 빠지지 않는다. 특히 비타민은 토마토 2개만 먹어도 권장량을 대부분 섭취할 수 있을 정도로 풍부하다. 또한 베타카로틴(450μg), 구연산, 사과산, 호박산, 루테인을 함유하고 있으며 특히 라이코펜 성분이 풍부하여 강력한 항암작용을 하며 멜라닌 색소 변형에 의한 주근깨 및 잡티를 예방하는데 도움을 주고 피부톤을 밝게 유지시켜주는데 도움을 준다. 또한 자외선으로부터 피부를 보호해주는 효과를 볼 수 있어 피부 미용에 도움이 된다. 또한 각종 항산화제를 많이 함유하고 있어 헤어 손상과 탈모 증상을 예방하는 효과도 있다.Tomato ( Solanum lyclpersicum ) is a plant belonging to the solanaceae family, and its fruits are edible. It is an annual plant native to Latin America, 1-3m tall with yellow flowers. The fruit is red due to lycopene. As a vine plant, it originally crawls on the ground and grows roots from the stem, but when grown, it is grown standing upright. It should be noted that solanine, a component of the seeds of species belonging to the Solanaceae family, is contained in very small amounts. Tomatoes were selected as one of the world's top 10 superfoods by Time magazine, and they are also called the fruit of heaven in the West because of their excellent taste and nutrition. There are about 500 varieties in addition to the well-known varieties such as Charlal Tomato, Cod Tomato, Stevia Tomato, Cherry Tomato, Date Tomato, and Black Tomato. 95% of tomato ingredients are water, and it is an alkaline food rich in vitamins and minerals. In particular, vitamins are rich enough to consume most of the recommended amount by eating just two tomatoes. It also contains beta-carotene (450μg), citric acid, malic acid, succinic acid, and lutein. It is especially rich in lycopene, which has a strong anti-cancer effect, helps prevent freckles and blemishes caused by melanin pigment transformation, and helps keep skin tone bright. give In addition, it can protect the skin from ultraviolet rays, which is helpful for skin beauty. In addition, it contains a lot of various antioxidants, so it is effective in preventing hair damage and hair loss symptoms.
브로콜리(Brassica Oleracea Italica)는 배추속의 한 종류인 브라시카 올레라케아에 속하는 채소의 일종이다. 브로콜리는 양배추류를 기원으로 하는 꽃양배추와 동일계통의 재배식물로서 꽃봉오리를 채소로 이용한다. 두툼한 줄기 끝에 작은 꽃이 무수히 달린 모양으로 브로콜리라는 말이 broccolo라는 이탈리어의 복수형으로 꽃이 피는 끝부분이라는 뜻이다. 다른 녹황색 채소들처럼 영양가가 풍부하다. 100g당 비타민E 함량은 상급에 들 정도로 우수하고 베타카로틴이나 비타민A도 당근, 시금치, 상추를 제외하면 상당히 많은 편이다. 브로콜리에는 설포라판이라는 항산화제로 전환되는 색소인 글루코라파닌이 많이 함유되어 있다. 설포라판은 강력한 항산화 효과를 갖는 것으로 알려져 있으며 최근에는 위염 발생의 원인균으로 알려진 헬리코박터 파일로리의 생육을 저해하며 위암 예방 효과까지 지니고 있는 것으로 보고되었다. 또한 루테인과 지아잔틴이 풍부하여 눈의 산화 스트레스와 세포 손상을 줄이는데 도움을 준다. 또한 브로콜리에는 아연, 칼슘, 엽산이 있어 머리털이 빠지는 것을 예방하고 모발 성장을 증강시킨다. 최근 브로콜리 속 NMN(nicotinamide mono nucleotide)이 장수물질로 불리우며 각종 질병과 노화현상을 억제한다는 논문도 발표되었다. '꿈의 물질'로 불리는 NMN은 체내에 존재하며 시르투인(Sirtuin)으로 불리는 장수(長壽)에 관여하는 유전자를 활성화시키는 역할을 하지만 나이가 들면 감소한다. 특히 브로콜리는 이러한 NMN 성분이 자연적으로 포함돼 있기 때문에 미국 국립암연구소가 뽑은 10대 암 예방 식품이자 대표적인 항산화 식품으로도 유명하다.Broccoli ( Brassica Oleracea Italica ) is a kind of vegetable belonging to Brassica oleracea, a type of cabbage. Broccoli is a cultivated plant of the same system as cauliflower, which originates from cabbage, and the bud is used as a vegetable. The word broccoli is the plural of the Italian word broccolo, meaning the end of a flower. Like other green leafy vegetables, it is rich in nutrients. Vitamin E content per 100g is excellent enough to be in the upper class, and beta-carotene and vitamin A are also quite high, except for carrots, spinach, and lettuce. Broccoli contains high amounts of glucoraphanin, a pigment that is converted to an antioxidant called sulforaphane. Sulforaphane is known to have a strong antioxidant effect, and has recently been reported to inhibit the growth of Helicobacter pylori, known as the causative agent of gastritis, and to have an effect of preventing gastric cancer. It is also rich in lutein and zeaxanthin, which help reduce oxidative stress and cell damage in the eyes. In addition, broccoli contains zinc, calcium, and folic acid, which prevent hair loss and enhance hair growth. Recently, a paper has been published that NMN (nicotinamide mononucleotide) in broccoli is called a longevity substance and suppresses various diseases and aging phenomena. NMN, called 'dream substance', exists in the body and plays a role in activating genes involved in longevity called sirtuin, but decreases with age. In particular, because broccoli naturally contains these NMN ingredients, it is famous as one of the top 10 cancer prevention foods and a representative antioxidant food selected by the National Cancer Institute in the United States.
본 발명의 토마토, 브로콜리 유래 엑소좀은 다음과 같은 방법으로 정제된다.Tomato and broccoli-derived exosomes of the present invention are purified by the following method.
(A)토마토 또는 브로콜리를 40~60℃, 20~24시간 열풍건조 처리하는 단계; (A) subjecting tomatoes or broccoli to hot air drying at 40 to 60° C. for 20 to 24 hours;
(B)열풍건조 처리한 토마토 또는 브로콜리를 30~40℃의 물에 6시간동안 침지하는 단계; (B) immersing tomatoes or broccoli treated with hot air drying in water at 30 to 40 ° C for 6 hours;
(C)침지시킨 토마토 또는 브로콜리에 UV-A를 1~6시간 처리하는 단계; (C) UV-A treatment of immersed tomatoes or broccoli for 1 to 6 hours;
(D)UV 처리한 토마토 또는 브로콜리를 착즙하는 단계; (D) squeezing UV-treated tomatoes or broccoli;
(E)상기 착즙액을 1,000xg~10,000xg에서 원심분리하여 상층액을 수득하는 단계; (E) obtaining a supernatant by centrifuging the juice at 1,000xg to 10,000xg;
(F)엑소좀이 존재하는 상기 상층액을 동결건조하는 단계; (F) freeze-drying the supernatant in which exosomes are present;
(G)상기 동결건조물에 PEG(Polyethylene glycol)/Dextran을 사용하여 수성 2상계를 형성하는 단계; 및 (G) forming an aqueous two-phase system using PEG (Polyethylene glycol)/Dextran in the lyophilisate; and
(H)상기 수성 2상계 중 엑소좀이 농축된 하층액을 수득하는 단계를 포함하는 방법에 의하여 정제된다.(H) obtaining an exosome-enriched lower layer in the aqueous two-phase system.
본 발명에서는 토마토, 브로콜리 유래 엑소좀을 제조하기 위하여 먼저 열풍건조 전처리를 수행한 후 UV-A 처리를 수행한다.In the present invention, in order to prepare tomato and broccoli-derived exosomes, pretreatment with hot air drying is performed first, followed by UV-A treatment.
식물의 경우 환경적인 요인에 의해 엑소좀의 분비량이 달라질 수 있으며 특히 식물이 스트레스를 받았을 때 엑소좀의 분비량에 영향을 줄 수 있다. 따라서 식물이 엑소좀을 분비하는 최적의 조건을 확인하기 위해 다양한 전처리를 통해 그 수율을 확인하였으며 토마토, 브로콜리는 열풍건조 및 UV-A 전처리 조건에 따라 엑소좀의 분비가 증가한다는 것을 확인하였다. 또한, 열풍건조 및 UV-A 전처리를 수행한 후 정제된 토마토, 브로콜리 엑소좀이 보다 우수한 피부 개선 및 모발개선효과를 나타냄을 확인하였다.In the case of plants, the amount of exosome secretion can vary depending on environmental factors, and in particular, the amount of exosome secretion can be affected when the plant is under stress. Therefore, in order to confirm the optimal conditions for plants to secrete exosomes, the yield was confirmed through various pretreatments, and it was confirmed that the secretion of exosomes increased in tomato and broccoli under hot air drying and UV-A pretreatment conditions. In addition, it was confirmed that the purified tomato and broccoli exosomes after hot air drying and UV-A pretreatment exhibited better skin and hair improvement effects.
본 발명의 바람직한 일 구체예에 따르면, 상기 (A) 단계에서 열풍건조 전처리는 토마토 또는 브로콜리를 열풍건조기를 이용하여 50℃에서 24시간 열풍건조 처리하는 것으로 이루어진다. According to a preferred embodiment of the present invention, the hot air drying pre-treatment in step (A) consists of hot air drying treatment for 24 hours at 50 ° C. using a hot air dryer for tomatoes or broccoli.
이어서, 열풍건조 전처리된 토마토, 브로콜리를 30~40℃의 물에 6시간 동안 침지시킨다((A), (B) 단계).Subsequently, tomatoes and broccoli pretreated with hot air drying are immersed in water at 30 to 40 ° C. for 6 hours (steps (A) and (B)).
상기 (C) 단계에서 침지시킨 토마토 또는 브로콜리를 365nm 파장의 UV-A에 1~6시간동안 노출시킨다.Tomatoes or broccoli immersed in step (C) are exposed to UV-A at a wavelength of 365 nm for 1 to 6 hours.
상기 (D) 단계에서 착즙하는 공정에 사용되는 스크류는 교반 속도가 20~50 rpm인 것을 사용하는 것이 바람직하다. In step (D), it is preferable to use a screw having an agitation speed of 20 to 50 rpm.
상기 (E) 단계에서 사용되는 원심분리법은 크기, 모양, 밀도, 점성, 로터 속도에 따른 원심력을 이용하여 용액의 입자를 분리해내는 방법을 의미한다. 순차적으로 rpm을 조절하여 큰 오염 물질 제거가 필요하며 수성 2상계를 형성하기 위한 최종 용액을 얻기 위해서는 10,000xg에서 수행하는 것이 더욱 바람직하다.The centrifugal separation method used in step (E) refers to a method of separating particles of a solution using centrifugal force according to size, shape, density, viscosity, and rotor speed. It is necessary to sequentially adjust the rpm to remove large contaminants, and it is more preferable to carry out at 10,000 x g to obtain a final solution for forming an aqueous two-phase system.
상기 (F) 단계에서 사용되는 동결건조는 용기의 온도를 급격하게 낮추어 건조시키고자 하는 물질을 얼린 다음 용기 내부의 압력을 진공에 가깝게 하여 재료에 포함된 고체화된 용매를 바로 수증기로 승화시켜 건조하는 방법이다. -50 ~ -80℃에서 15~24시간동안 동결하고, 동결건조기에서 진공상태로 72~120시간동안 건조한다. 이때 진공상태는 통상 동결건조기의 압력 상태를 의미한다.The freeze-drying used in step (F) rapidly lowers the temperature of the container to freeze the material to be dried, and then the pressure inside the container is close to vacuum to sublimate the solidified solvent contained in the material into water vapor and dry it way. Freeze at -50 ~ -80 ℃ for 15 ~ 24 hours, and dry for 72 ~ 120 hours in a vacuum state in a freeze dryer. At this time, the vacuum state usually means the pressure state of the freeze dryer.
엑소좀을 효율적으로 분리 정제하기 위하여 본 발명에서는 상호간에 잘 용해되지 않은 2종류의 수용액으로 2층을 만들어 각층으로의 친화성 차이를 이용한 분리법의 하나인 수성 2상분배법(aqueous two phase partition method)을 사용하였다.In order to efficiently separate and purify exosomes, in the present invention, an aqueous two phase partition method, which is one of the separation methods using the difference in affinity between each layer by making two layers with two types of aqueous solutions that are not well dissolved in each other, is used. ) was used.
수성 2상계를 형성하는 방법에는 일반적으로 PEG/염(염으로는 sulfate, phosphate, citrate 등)도 사용할 수 있으나, 본 발명의 목적을 달성하기 위해서는 PEG/Dextran을 사용하는 것이 바람직하다. Dextran은 박테리아 작용에 의해 얻은 천연 고분자로 화장품 제형에서 점증제, 결합제, 벌킹제로 사용한다. Although PEG/salts (salts such as sulfate, phosphate, citrate, etc.) can also be used in the method of forming an aqueous two-phase system, it is preferable to use PEG/Dextran to achieve the object of the present invention. Dextran is a natural polymer obtained by bacterial action and is used as a thickener, binder, and bulking agent in cosmetic formulations.
상기 (G) 단계에서 수성 2상계의 형성에 있어서 PEG는 분자량이 10,000~35,000인 것을 1~15중량%, 바람직하게는 2~5중량% 사용하고 Dextran은 분자량이 300,000~650,000인 것을 1~8 중량%, 바람직하게는 1~3중량% 사용하는 것을 특징으로 한다. 상기 PEG와 Dextran이 3.3중량%: 1.7중량%의 농도비율로 사용되는 경우에 엑소좀의 수율이 가장 높고, 안정성이 가장 우수하므로 더욱 바람직하다.In the formation of the aqueous two-phase system in step (G), PEG is used in an amount of 1 to 15% by weight, preferably 2 to 5% by weight, with a molecular weight of 10,000 to 35,000, and Dextran is used in an amount of 1 to 8 with a molecular weight of 300,000 to 650,000 It is characterized by using weight%, preferably 1 to 3% by weight. When the PEG and Dextran are used in a concentration ratio of 3.3% by weight: 1.7% by weight, the yield of exosomes is the highest and the stability is the best, so it is more preferable.
엑소좀의 순도를 높이기 위해, 상기 (H)단계에 이어서 동일한 농도의 수성 2상계 용액을 사용하여 수성 2상계를 형성하고 하층액을 수득하는 과정을 2~3회 수행하는 공정을 추가적으로 수행할 수 있다.In order to increase the purity of exosomes, following the step (H), a step of forming an aqueous two-phase system using an aqueous two-phase solution of the same concentration and obtaining a lower layer solution can be additionally performed 2-3 times. there is.
이와 같은 방법에 의하여 제조된 토마토 엑소좀, 브로콜리 엑소좀 및 그 혼합 엑소좀은 일반 토마토 추출물, 브로콜리 추출물과 비교하여, 그리고 전처리를 수행하지 않고 정제한 엑소좀과 비교하여 우수한 미백 효과(시험예 7, 시험예 8), 항염 효과(시험예 9, 시험예 10), 피부진정 효과(시험예 11), 모발 성장 촉진 효과(시험예 12), 탈모방지 효과(시험예 13, 시험예 14)를 나타내었다.Tomato exosomes, broccoli exosomes, and mixed exosomes prepared by this method have excellent whitening effect compared to general tomato extract and broccoli extract and compared to exosomes purified without pretreatment (Test Example 7 , Test Example 8), anti-inflammatory effect (Test Example 9, Test Example 10), skin soothing effect (Test Example 11), hair growth promoting effect (Test Example 12), hair loss prevention effect (Test Example 13, Test Example 14) showed up
그러므로 상기 토마토, 브로콜리 유래 엑소좀은 미백용, 항염용, 피부진정용 화장료 조성물에 사용될 수 있으며, 또한 모발 성장 촉진용, 탈모방지용 화장료 조성물에도 사용될 수 있다. 이때 상기 유효성분으로서의 토마토, 브로콜리 유래 엑소좀은 화장료 조성물 전체 중량에 대하여 0.0001 내지 30.0%(w/w) 함유될 수 있다.Therefore, the tomato and broccoli-derived exosomes can be used in cosmetic compositions for whitening, anti-inflammatory, and skin soothing, and can also be used in cosmetic compositions for promoting hair growth and preventing hair loss. At this time, tomato and broccoli-derived exosomes as the active ingredient may be contained in an amount of 0.0001 to 30.0% (w/w) based on the total weight of the cosmetic composition.
상기 화장료 조성물은 통상적으로 제조되는 어떠한 제형으로도 가능하며 예를 들면, 스킨로션, 스킨토너, 팩, 영양크림, 수분 크림, 에센스, 바디크림, 바디로션, 바디오일, 클렌징폼, 클렌징로션, 비누, 패치, 파운데이션, 립스틱, 메이크업 베이스, 립스틱 등으로 제조될 수 있다.The cosmetic composition can be any formulation that is conventionally manufactured, and for example, skin lotion, skin toner, pack, nutrient cream, moisture cream, essence, body cream, body lotion, body oil, cleansing foam, cleansing lotion, soap , patches, foundations, lipsticks, makeup bases, lipsticks, and the like.
또한 상기 화장료 조성물은 예를 들면, 헤어 토닉, 헤어 로션, 헤어 오일, 헤어 샴푸, 헤어 린스, 헤어 컨디셔너, 헤어 트리트먼트, 헤어 크림, 헤어 팩, 헤어 스프레이, 헤어 에센스, 헤어 무스, 헤어 겔 등으로 제조될 수 있다.In addition, the cosmetic composition may be, for example, hair tonic, hair lotion, hair oil, hair shampoo, hair rinse, hair conditioner, hair treatment, hair cream, hair pack, hair spray, hair essence, hair mousse, hair gel, etc. can be manufactured.
[실시예] [Example]
이하, 본 발명을 하기의 실시예 및 시험예에 의거하여 좀 더 상세하게 설명한다. 단, 하기 실시예는 본 발명을 예시하기 위한 것일 뿐, 본 발명이 하기 실시예에 의해 한정되는 것이 아니고, 본 발명의 기술적 사상을 벗어나지 않는 범위 내에서 치환 및 균등한 타 실시예로 변경할 수 있음은 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 있어서 명백할 것이다.Hereinafter, the present invention will be described in more detail based on the following examples and test examples. However, the following examples are only for exemplifying the present invention, and the present invention is not limited by the following examples, and may be replaced with other equivalent examples without departing from the technical spirit of the present invention. will be clear to those skilled in the art to which the present invention pertains.
실시예 1: 토마토 엑소좀의 제조Example 1: Preparation of Tomato Exosomes
토마토 열풍건조 처리Tomato hot air drying treatment
토마토 생물 200g을 열풍건조기를 이용하여 50℃의 온도에서 24hr 열풍건조 처리를 실행하였다.200 g of tomato organisms were subjected to hot air drying treatment at a temperature of 50° C. for 24 hr using a hot air dryer.
토마토 침지tomato dipping
열풍건조 처리한 토마토를 약 30~40℃의 물에 6시간동안 침지시켰다.Tomatoes treated with hot air drying were immersed in water at about 30 to 40 ° C. for 6 hours.
토마토 UV-A 처리Tomato UV-A treatment
침지 시킨 토마토에 365nm 파장의 UV-A를 6시간동안 처리하였다.The immersed tomatoes were treated with UV-A at a wavelength of 365 nm for 6 hours.
토마토 착즙tomato juice
UV 처리한 토마토를 일반 착즙기를 사용하여 30 rpm의 저속 스크류로 토마토 착즙을 수행하였으며 수득한 토마토 착즙액은 메쉬망에 걸러 부유물을 제거하였다. 회수한 토마토 착즙액은 정제를 진행하기 전까지 -80℃에서 보관하였다.UV-treated tomatoes were subjected to tomato juice with a low-speed screw at 30 rpm using a general juicer, and the obtained tomato juice was filtered through a mesh net to remove suspended matter. The recovered tomato juice was stored at -80 ° C until purification.
엑소좀 정제를 위한 상층액 회수Supernatant Recovery for Exosome Purification
토마토 착즙액은 엑소좀 정제를 위해 큰 오염 물질 제거가 필요하기 때문에 10,000xg에서 10분동안 4℃에서 원심분리를 수행하였다. 원심분리를 수행 후 수성 2상계를 형성하기 위해 상층액을 회수하였다.Tomato juice was centrifuged at 4° C. for 10 minutes at 10,000xg because removal of large contaminants was required for exosome purification. After centrifugation, the supernatant was recovered to form an aqueous two-phase system.
상층액 동결건조Freeze-drying of the supernatant
엑소좀의 대량생산을 위해 상층액의 부피를 줄이는 목적으로 동결건조를 수행하였다. -80℃에서 20시간동안 동결하고, 동결건조기에서 진공상태로 100시간동안 건조하였다. 이때 진공상태는 통상 동결건조기의 압력 상태를 의미하며 동결 및 건조 시간은 용액의 부피에 따라 달라질 수 있다.Freeze-drying was performed for the purpose of reducing the volume of the supernatant for mass production of exosomes. It was frozen at -80 ° C for 20 hours and dried for 100 hours in a vacuum in a freeze dryer. At this time, the vacuum state usually means the pressure state of the freeze dryer, and the freezing and drying time may vary depending on the volume of the solution.
수성 2상계 형성 Formation of an aqueous two-phase system
동결건조한 상층액에 정제수를 추가하고 PEG(Polyethylene glycol)/Dextran을 사용하여 수성 2상계를 형성하였다. PEG (Sigma Aldrich에서 구매)는 분자량이 10,000~35,000인 것을 3.3 중량% 사용하고 Dextran (Sigma Aldrich에서 구매)은 분자량이 300,000~650,000인 것을 1.7 중량% 사용하여 수성 2상 시스템을 형성하였다.Purified water was added to the lyophilized supernatant, and an aqueous two-phase system was formed using PEG (Polyethylene glycol)/Dextran. An aqueous two-phase system was formed using 3.3% by weight of PEG (purchased from Sigma Aldrich) with a molecular weight of 10,000 to 35,000 and 1.7% by weight of Dextran (purchased from Sigma Aldrich) with a molecular weight of 300,000 to 650,000.
토마토 엑소좀의 회수Recovery of tomato exosomes
상층액과 PEG/Dextran 용액을 혼합한 후 1,000xg에서 10분동안 4℃에서 원심분리를 수행하였다. 원심분리 후 상층액을 제거하여 엑소좀을 회수하였다. After mixing the supernatant and the PEG/Dextran solution, centrifugation was performed at 1,000xg for 10 minutes at 4°C. After centrifugation, the supernatant was removed to recover exosomes.
추가 세척 공정Additional cleaning process
순도를 높이기 위해 회수된 하층액에 동일한 농도의 상기 수성 2상계 용액을 넣어 추가 세척 공정을 수행하였다. 3회 반복 처리 후 최종 엑소좀이 농축된 하층액을 회수하였다.In order to increase the purity, an additional washing process was performed by adding the aqueous two-phase solution having the same concentration to the recovered lower layer. After repeated treatment three times, the final exosome-concentrated subnatant was recovered.
실시예 2: 브로콜리 엑소좀의 제조Example 2: Preparation of broccoli exosomes
상기 실시예 1과 동일하게 하여 브로콜리 유래 엑소좀을 정제하였다.Broccoli-derived exosomes were purified in the same manner as in Example 1.
실시예 3: 토마토, 브로콜리 혼합 엑소좀의 제조Example 3: Preparation of Tomato and Broccoli Mixed Exosomes
상기 실시예 1, 2에서 제조한 토마토 엑소좀과 브로콜리 엑소좀을 동일 중량비율로 혼합하여 혼합 엑소좀을 제조하였다.Mixed exosomes were prepared by mixing the tomato exosomes prepared in Examples 1 and 2 and the broccoli exosomes in the same weight ratio.
실시예 4~15: 토마토, 브로콜리 엑소좀의 제조Examples 4 to 15: Preparation of tomato and broccoli exosomes
식물의 경우 환경적인 요인에 의해 엑소좀의 분비량이 달라질 수 있다. 식물이 엑소좀을 분비하는 최적의 조건이 모두 다르기 때문에 UV 처리 스트레스에 의한 엑소좀의 수율 비교를 통해 최적의 건조 조건을 확립하기 위해 토마토와 브로콜리의 UV 처리 조건을 달리하여 엑소좀을 정제하였다. 실시예 4와 실시예 10을 제외하고는 UV 처리 조건만을 달리하여 상기 실시예 1과 동일하게 엑소좀을 정제하였으며 UV 처리 조건은 하기의 표 1에 나타내었다. 실시예 4와 실시예 10은 토마토와 브로콜리 생물을 열풍건조와 UV 전처리없이 바로 착즙하여 수성 2상 시스템을 적용하여 정제하였다.In the case of plants, the amount of exosome secretion may vary depending on environmental factors. Since the optimum conditions for plant secretion of exosomes are all different, exosomes were purified by varying the UV treatment conditions of tomatoes and broccoli in order to establish optimal drying conditions through comparison of exosome yields by UV treatment stress. Exosomes were purified in the same manner as in Example 1 except for Example 4 and Example 10, except for the UV treatment conditions, and the UV treatment conditions are shown in Table 1 below. In Examples 4 and 10, tomato and broccoli organisms were directly extracted without hot air drying and UV pretreatment, and purified by applying an aqueous two-phase system.
비교예 1: 토마토 추출물 제조Comparative Example 1: Preparation of tomato extract
토마토 건조물 10g을 정제수 100g에 넣고 80℃에서 3시간동안 추출하였다. 추출 후 감압여과를 수행하여 토마토 추출물을 얻은 후 회전증발농축기를 사용하여 증류하여 파우더 형태로 샘플을 수득하였다.10 g of dried tomato was added to 100 g of purified water and extracted at 80° C. for 3 hours. After extraction, filtration under reduced pressure was performed to obtain a tomato extract, followed by distillation using a rotary evaporator to obtain a sample in powder form.
비교예 2: 브로콜리 추출물 제조Comparative Example 2: Preparation of broccoli extract
브로콜리 건조물 10g을 정제수 100g에 넣고 80℃에서 3시간동안 추출하였다. 추출 후 감압여과를 수행하여 브로콜리 추출물을 얻은 후 회전증발농축기를 사용하여 증류하여 파우더 형태로 샘플을 수득하였다.10 g of dried broccoli was added to 100 g of purified water and extracted at 80° C. for 3 hours. After extraction, vacuum filtration was performed to obtain a broccoli extract, and then distillation was performed using a rotary evaporator to obtain a sample in powder form.
시험예 1: 토마토 유래 엑소좀의 특성 분석: TEM 분석 Test Example 1: Characterization of tomato-derived exosomes: TEM analysis
정제한 토마토 유래 엑소좀의 모양을 확인하기 위해 투과 전자 현미경(TEM)으로 분석하였다. 도 1은 상기 실시예 1에 따라서 정제된 토마토 유래 엑소좀의 TEM 분석 이미지이다. 분석 결과, 구형의 인지질 이중층 구조로 된 약 160nm의 입자의 존재를 확인하였다.In order to confirm the shape of the purified tomato-derived exosomes, they were analyzed by transmission electron microscopy (TEM). 1 is a TEM analysis image of tomato-derived exosomes purified according to Example 1 above. As a result of the analysis, the existence of about 160 nm particles having a spherical phospholipid bilayer structure was confirmed.
시험예 2: 브로콜리 유래 엑소좀의 특성 분석: TEM 분석 Test Example 2: Characterization of broccoli-derived exosomes: TEM analysis
정제한 브로콜리 유래 엑소좀의 모양을 확인하기 위해 투과 전자 현미경(TEM)으로 분석하였다. 도 2는 상기 실시예 2에 따라서 정제된 브로콜리 유래 엑소좀의 TEM 분석 이미지이다. 분석 결과, 구형의 인지질 이중층 구조로 된 약 160nm의 입자의 존재를 확인하였다.In order to confirm the shape of the purified broccoli-derived exosomes, they were analyzed by transmission electron microscopy (TEM). 2 is a TEM analysis image of broccoli-derived exosomes purified according to Example 2 above. As a result of the analysis, the existence of about 160 nm particles having a spherical phospholipid bilayer structure was confirmed.
시험예 3: 토마토 유래 엑소좀의 특성 분석: NTA 분석Experimental Example 3: Characterization of tomato-derived exosomes: NTA analysis
정제한 토마토 유래 엑소좀의 입자 크기 분포와 단위 부피당 입자 수를 확인하기 위해 나노입자추적분석(Nanoparticle Tracking Analysis, NTA)으로 분석하였다. The purified tomato-derived exosomes were analyzed by Nanoparticle Tracking Analysis (NTA) to confirm the particle size distribution and number of particles per unit volume.
도 3은 상기 실시예 1에 따라서 정제된 토마토 유래 엑소좀의 NTA 분석 결과를 나타낸 그래프이며 분석 결과, 입자들의 평균 크기 159.7nm와 1 mL의 단위 부피당 6.40 x 1010 개의 농도를 확인하였다. 3 is a graph showing the results of NTA analysis of tomato-derived exosomes purified according to Example 1. As a result of the analysis, the average particle size of 159.7 nm and the concentration of 6.40 x 10 10 particles per unit volume of 1 mL were confirmed.
시험예 4: 브로콜리 유래 엑소좀의 특성 분석: NTA 분석Test Example 4: Characterization of broccoli-derived exosomes: NTA analysis
정제한 브로콜리 유래 엑소좀의 입자 크기 분포와 단위 부피당 입자 수를 확인하기 위해 나노입자추적분석(Nanoparticle Tracking Analysis, NTA)으로 분석하였다. In order to confirm the particle size distribution and the number of particles per unit volume of the purified broccoli-derived exosomes, nanoparticle tracking analysis (NTA) was analyzed.
도 4는 상기 실시예 2에 따라서 정제된 브로콜리 유래 엑소좀의 NTA 분석 결과를 나타낸 그래프이며 분석 결과, 입자들의 평균 크기 167.3nm와 1 mL의 단위 부피당 5.90 x 1010 개의 농도를 확인하였다. 4 is a graph showing the results of NTA analysis of broccoli-derived exosomes purified according to Example 2. As a result of the analysis, it was confirmed that the particles had an average size of 167.3 nm and a concentration of 5.90 x 10 10 particles per unit volume of 1 mL.
시험예 5: 토마토, 브로콜리 유래 엑소좀의 수율 비교Test Example 5: Comparison of the yield of tomato and broccoli-derived exosomes
열풍건조 및 UV 처리의 최적 조건을 확인하기 위해 상기 실시예 1, 2 및 4~15에 따라 정제한 토마토, 브로콜리 유래 엑소좀의 수율을 비교하였다. 하기 표 2는 수율 비교를 나노입자추적분석(NTA) 결과로 나타낸 표이다.In order to confirm the optimal conditions for hot air drying and UV treatment, the yields of tomato and broccoli-derived exosomes purified according to Examples 1, 2 and 4 to 15 were compared. Table 2 below is a table showing yield comparison as a result of nanoparticle tracking analysis (NTA).
(Particles/ml)Particle Number
(Particles/ml)
(nm)Particle Size
(nm)
상기 표 2에서 확인되는 바와 같이 열풍건조 처리 후 UV 처리를 했을 때(실시예 5, 6, 11, 12) 높은 수율을 나타내었으며, 그 중에서도 UV를 6시간 동안 처리한 조건인 실시예 1, 2에서 엑소좀의 수율이 가장 높았다. 실시예 4와 실시예 10의 결과로 보았을 때 열풍건조 및 UV 전처리를 수행하지 않은 엑소좀의 경우 가장 낮은 수율을 보였다. 이는 전처리 조건의 엑소좀의 수율에 큰 영향을 주는 것으로 확인되었으며 따라서 가장 최적의 조건은 열풍건조 전처리 후 UV-A 6시간 처리임을 확인하였다.As confirmed in Table 2, when UV treatment was performed after hot air drying treatment (Examples 5, 6, 11, and 12), high yields were exhibited, and among them, Examples 1 and 2 under the condition of UV treatment for 6 hours The yield of exosomes was the highest in . Judging from the results of Example 4 and Example 10, exosomes not subjected to hot air drying and UV pretreatment showed the lowest yield. This was confirmed to have a significant effect on the yield of exosomes under pretreatment conditions, and therefore, it was confirmed that the most optimal conditions were pretreatment with hot air drying followed by UV-A treatment for 6 hours.
시험예 6: 세포독성 평가Test Example 6: Evaluation of cytotoxicity
토마토 엑소좀(실시예 1, 실시예 4), 브로콜리 엑소좀(실시예 2, 실시예 10) 및 그 혼합엑소좀(실시예 3)과 토마토 추출물(비교예 1), 브로콜리 추출물(비교예 2)의 세포독성을 확인하기 위해 MTT assay 평가를 진행하였다. 96well 플레이트에 사람의 섬유아세포 세포주(human dermal fibroblast, HDFa)를 1×105 cells/mL의 농도로 접종 후 37℃로 18시간동안 5% CO2 하에 배양하였다. Tomato exosome (Example 1, Example 4), broccoli exosome (Example 2, Example 10) and its mixed exosome (Example 3) and tomato extract (Comparative Example 1), broccoli extract (Comparative Example 2 ), MTT assay was evaluated to confirm the cytotoxicity. Human fibroblast cell line (human dermal fibroblast, HDFa) was inoculated in a 96-well plate at a concentration of 1×10 5 cells/mL, and then incubated at 37° C. for 18 hours under 5% CO 2 .
배양 후, 배지를 제거하고 PBS buffer로 세척한 후 새로운 배지에 토마토 엑소좀, 브로콜리 엑소좀, 그 혼합 엑소좀 및 토마토 추출물, 브로콜리 추출물을 농도 별로 투여하고 다시 24시간동안 배양하였다. 세포의 생존율을 측정하기 위해 MTT solution (5mg/mL)을 첨가한 후 4시간 동안 형성된 formazan을 Dimethyl sulfoxide(DMSO)로 용해하고 ELISA reader를 이용하여 570nm에서 흡광도를 측정하였다. After culturing, the medium was removed, washed with PBS buffer, and then tomato exosomes, broccoli exosomes, the mixed exosomes, tomato extract, and broccoli extract were administered to a new medium by concentration and cultured again for 24 hours. To measure cell viability, MTT solution (5mg/mL) was added, formazan formed for 4 hours was dissolved in dimethyl sulfoxide (DMSO), and absorbance was measured at 570 nm using an ELISA reader.
도 5는 상기 시료들의 세포독성을 MTT assay로 평가한 결과를 나타낸 그래프이다. 시험 결과, 토마토 엑소좀, 브로콜리 엑소좀, 토마토와 브로콜리 혼합 엑소좀 및 토마토 추출물, 브로콜리 추출물을 처리하였을 때 모든 농도에서 세포독성이 나타나지 않았다.5 is a graph showing the results of evaluating the cytotoxicity of the samples by MTT assay. As a result of the test, when the tomato exosome, broccoli exosome, tomato and broccoli mixed exosome, tomato extract, and broccoli extract were treated, no cytotoxicity was observed at all concentrations.
시험예 7: 토마토, 브로콜리 엑소좀의 미백 효능 평가(티로시나아제 활성 억제)Test Example 7: Evaluation of whitening efficacy of tomato and broccoli exosomes (tyrosinase activity inhibition)
Tyrosinase에 의해 tyrosine 이 dopaquinone으로 산화되면서 피부에서는 색소침착이 일어난다. 엑소좀의 미백 효능을 확인하기 위해 추출물과 비교하여 피부를 검게 만드는 티로시나아제 효소 활성 억제 시험을 진행하였다. 버섯 유래의 티로시나아제와 티로신은 Sigma Chemical에서 구매하여 사용하였으며, 티로시나제 활성은 0.1M 포스페이트 버퍼(pH 6.5) 150㎕ 와 버섯 티로시나제(2100unit/㎖, 0.05M 포스페이트 버퍼, pH 6.5) 8㎕, 1.5mM 농도의 L-티로신 36㎕ 와 함께 토마토 엑소좀, 브로콜리 엑소좀, 그 혼합 엑소좀과 토마토 추출물, 브로콜리 추출물을 농도별로 처리하였다. 티로시나아제 억제 활성은 시료를 37℃에서 15분 동안 반응을 진행한 후 490 nm에서 흡광도를 측정하여 확인하였다. 이때 음성 대조군으로는 PBS를 처리하였으며 양성 대조군으로는 Niacinamide 0.01%를 처리하였다. As tyrosine is oxidized to dopaquinone by tyrosinase, pigmentation occurs in the skin. In order to confirm the whitening efficacy of the exosomes, a tyrosinase enzyme activity inhibition test was conducted to darken the skin compared to the extract. Mushroom-derived tyrosinase and tyrosine were purchased and used from Sigma Chemical. For tyrosinase activity, 0.1M phosphate buffer (pH 6.5) 150μl and mushroom tyrosinase (2100unit/ml, 0.05M phosphate buffer, pH 6.5) 8μl, 1.5 Tomato exosomes, broccoli exosomes, their mixed exosomes, tomato extract, and broccoli extract were treated with 36 μl of L-tyrosine at mM concentration for each concentration. Tyrosinase inhibitory activity was confirmed by measuring the absorbance at 490 nm after the sample was reacted at 37° C. for 15 minutes. At this time, PBS was treated as a negative control, and Niacinamide 0.01% was treated as a positive control.
도 6은 상기 실시예에 따라서 정제된 토마토, 브로콜리 유래 엑소좀의 미백 효능을 티로시나아제 활성 억제율로 평가한 결과를 나타낸 그래프이다. 시험 결과, 토마토 엑소좀, 브로콜리 엑소좀과 토마토 추출물, 브로콜리 추출물을 처리하였을 때 농도 의존적으로 티로시나아제 활성 억제율이 증가하였으며, 추출물에 비해 토마토, 브로콜리 유래 엑소좀을 처리하였을 때 활성 억제율이 더 증가됨을 확인하였다. 또한 토마토와 브로콜리 혼합 엑소좀을 처리하였을 때 가장 높은 활성 억제율을 나타내는 것을 확인하였다. 이때 양성 대조군인 Niacinamide 0.01%를 처리하였을 때는 40.2% 억제율을 보였다.6 is a graph showing the results obtained by evaluating the whitening efficacy of tomato and broccoli-derived exosomes purified according to the above example in terms of tyrosinase activity inhibition rate. As a result of the test, when tomato exosomes, broccoli exosomes, tomato extract, and broccoli extract were treated, the tyrosinase activity inhibition rate increased in a concentration-dependent manner, and when tomato and broccoli-derived exosomes were treated, the activity inhibition rate was further increased confirmed. In addition, it was confirmed that the highest activity inhibition rate was obtained when the tomato and broccoli mixed exosomes were treated. At this time, when Niacinamide 0.01%, a positive control, was treated, 40.2% inhibition rate was shown.
시험예 8: 토마토, 브로콜리 엑소좀의 미백 효능 평가(멜라닌 생성 억제)Test Example 8: Evaluation of whitening efficacy of tomato and broccoli exosomes (inhibition of melanin production)
토마토, 브로콜리 유래 엑소좀의 미백 효능을 확인하기 위해 추출물과 비교하여 멜라닌 생성 억제 시험을 진행하였다. 마우스에서 유래한 B16F10 세포주(멜라닌 분비 세포)를 접종 후 10% FBS를 첨가한 Dulbecco Modified Eagle Medium (DMEM) 배양 배지에서 37℃로 24시간동안 5% CO2 하에 배양하였다. 배양 후 배지를 버리고 새 배지로 교체 후 토마토 엑소좀, 브로콜리 엑소좀, 그 혼합 엑소좀과 토마토 추출물, 브로콜리 추출물을 농도별로 처리하고 72시간 배양하였다. 배양 후 세포를 Trypsin-EDTA를 처리 후 원심분리하여 회수하였다. 회수한 세포를 세척 후 1N NaOH 500μL를 처리하고 100℃에서 10분간 반응시켜 멜라닌을 용해하였다. 멜라닌의 양은 405nm에서 흡광도를 측정하여 확인하였다. 이때 음성 대조군으로는 PBS를 처리하였으며 미백제로 알려진 합성물질인 arbutin을 표준시료로 사용하고 결과는 %로 환산하였다. In order to confirm the whitening efficacy of tomato and broccoli-derived exosomes, a melanin production inhibition test was conducted in comparison with the extracts. B16F10 cell line (melanin-secreting cells) derived from mice was inoculated and cultured in Dulbecco Modified Eagle Medium (DMEM) culture medium supplemented with 10% FBS at 37° C. for 24 hours under 5% CO 2 . After culturing, the medium was discarded and replaced with a new medium, and then the tomato exosomes, the broccoli exosomes, the mixed exosomes, the tomato extract, and the broccoli extract were treated by concentration and cultured for 72 hours. After culturing, the cells were recovered by centrifugation after treatment with Trypsin-EDTA. The recovered cells were washed, treated with 500 μL of 1N NaOH, and reacted at 100° C. for 10 minutes to dissolve melanin. The amount of melanin was confirmed by measuring absorbance at 405 nm. At this time, PBS was treated as a negative control, and arbutin, a synthetic material known as a whitening agent, was used as a standard sample, and the result was converted into %.
도 7은 상기 실시예에 따라서 정제된 토마토, 브로콜리 유래 엑소좀의 미백 효능을 멜라닌 생성 억제율로 평가한 결과를 나타낸 그래프이다. 시험 결과, 토마토 엑소좀, 브로콜리 엑소좀과 토마토 추출물, 브로콜리 추출물을 처리하였을 때 농도 의존적으로 멜라닌 생성 억제율이 증가하였으며, 추출물에 비해 토마토, 브로콜리 유래 엑소좀을 처리하였을 때 생성 억제율이 더 증가됨을 확인하였다. 또한 토마토와 브로콜리 혼합 엑소좀을 처리하였을 때 가장 높은 멜라닌 생성 억제율을 나타내는 것을 확인하였다.7 is a graph showing the results obtained by evaluating the whitening efficacy of tomato and broccoli-derived exosomes purified according to the above example in terms of melanin production inhibition rate. As a result of the test, when tomato exosomes, broccoli exosomes, tomato extract, and broccoli extract were treated, the melanin production inhibition rate increased in a concentration-dependent manner. did In addition, it was confirmed that the highest melanin production inhibition rate was obtained when the tomato and broccoli mixed exosomes were treated.
시험예 9: 토마토, 브로콜리 엑소좀의 항염 효능 평가(IL-1 발현 억제)Test Example 9: Evaluation of anti-inflammatory efficacy of tomato and broccoli exosomes (inhibition of IL-1 expression)
토마토, 브로콜리 유래 엑소좀의 항염 효능을 확인하기 위해 추출물과 비교하여 IL-1 mRNA 발현 억제 시험을 진행하였다. Human Keratinocyte(HaCaT) 세포를 6x105 cells/well 농도로 접종한 후 70~80% 정도 자랄 때까지 37℃ 5% CO2의 조건에서 24 시간 배양한 후, 각 웰의 배지를 제거하고 새로운 serum-free DMEM으로 교체하였다. 각 웰에 토마토 엑소좀, 브로콜리 엑소좀 및 토마토 추출물, 브로콜리 추출물을 농도 별로 투여하여 4시간 전처리를 수행하였다. 각 well plate에 UVB 조사장치(vilber loumet, France)에 의해 10mJ/cm2 UVB를 조사하였다. 시료를 희석한 serum-free DMEM 배양배지를 처리한 후 24시간 동안 추가 배양하였다. 이때 음성 대조군으로는 PBS를 처리하였으며 양성 대조군으로는 Allantoin을 0.01% 처리하였다. Ribo Ex TM Total RNA Isolation Solution(GeneAll Biotechnology, Korea)와 scraper를 이용하여 세포배양이 끝난 세포를 용해한 다음 0.2mL 클로로포름(Sigma-Aldrich, USA)을 첨가하여 원심 분리(12,000rpm, 4℃ 30분)한다. RNA가 있는 상층액을 분리하여 아이소프로판올(Merck-Millipore, Germany)을 상층액과 동량 넣어 inverting 후 원심 분리(12,000rpm, 4℃ 30분)한다. RNA를 침전시켜 침전물을 제외한 상층액은 버린 후 남아있는 침전물에 ethanol(Merck-Millipore, Germany) 70%를 넣어 원심 분리(12,000rpm, 4℃ 10분)하여 세척한다. Ethanol을 제거하고 상온에서 건조시킨 후, Nuclease-Free Water(Affymetrix, USA)로 용해하여 total RNA를 추출하였다. MaestroNano® Micro-volume Spectrophotometer(MN-913, Maestrogen, USA)를 이용하여 A260/A280 파장에서 RNA의 순도와 농도를 측정한 뒤, 260 nm와 280 nm의 비가 2.0-2.2 범위에 해당함을 확인하였다. cDNA는 PCR tube에 1μg RNA와 Oligo dT(Bionics, Korea) dNTP(Takara, Korea), nuclease free water를 total 13μL로 제조한 다음 65℃에서 5분 반응시킨 후, M-MLV Reverse Transcriptase (Invitrogen, Thermo Fisher Scientific, Waltham, Massachusetts, USA)를 이용하여 37℃에서 50분 반응시켜 합성하였다. 시료에 의한 각 세포 내에서 일어나는 유전자 발현 패턴을 정량적으로 분석하기 위하여 qRT-PCR을 실행하였다. qRT-PCR은 PCR tube에 primer, cDNA, 2X SYBR green PCR Master Mix(Applied Biosystems, USA), HPLC(J. T baker, USA)를 total 20μL로 혼합하여 반응액을 만들어 StepOnePlus Real-Time PCR System(Applied Biosystems, USA)을 사용하여 PCR을 진행하였다. In order to confirm the anti-inflammatory efficacy of tomato and broccoli-derived exosomes, an IL-1 mRNA expression inhibition test was performed in comparison with the extracts. Human Keratinocyte (HaCaT) cells were inoculated at a concentration of 6x10 5 cells/well and cultured for 24 hours at 37℃ and 5% CO 2 until they reached 70-80% growth. It was replaced with free DMEM. Tomato exosomes, broccoli exosomes, tomato extract, and broccoli extract were administered to each well at different concentrations, and pretreatment was performed for 4 hours. Each well plate was irradiated with 10 mJ/cm 2 UVB by a UVB irradiator (Vilber Loumet, France). Samples were further cultured for 24 hours after treatment with diluted serum-free DMEM culture medium. At this time, PBS was treated as a negative control group, and 0.01% Allantoin was treated as a positive control group. Ribo Ex TM Total RNA Isolation Solution (GeneAll Biotechnology, Korea) and scraper were used to dissolve cells after cell culture, and then centrifugation (12,000 rpm, 4℃ for 30 minutes) by adding 0.2mL chloroform (Sigma-Aldrich, USA) do. Separate the supernatant with RNA, add isopropanol (Merck-Millipore, Germany) in the same amount as the supernatant, invert, and centrifuge (12,000 rpm, 4℃ for 30 minutes). RNA was precipitated and the supernatant except for the precipitate was discarded, and the remaining precipitate was washed with 70% ethanol (Merck-Millipore, Germany) and centrifuged (12,000 rpm, 4 ° C for 10 minutes). After removing ethanol and drying at room temperature, total RNA was extracted by dissolving in Nuclease-Free Water (Affymetrix, USA). After measuring the purity and concentration of RNA at the A260/A280 wavelength using a MaestroNano ® Micro-volume Spectrophotometer (MN-913, Maestrogen, USA), it was confirmed that the ratio of 260 nm and 280 nm was in the range of 2.0-2.2. For cDNA, 1 μg RNA, Oligo dT (Bionics, Korea), dNTP (Takara, Korea), and nuclease free water were prepared in a PCR tube in a total of 13 μL, reacted at 65 ° C for 5 minutes, and then M-MLV Reverse Transcriptase (Invitrogen, Thermo Fisher Scientific, Waltham, Massachusetts, USA) was synthesized by reacting at 37 ° C. for 50 minutes. qRT-PCR was performed to quantitatively analyze gene expression patterns occurring within each cell by the sample. For qRT-PCR, a total of 20 μL of primer, cDNA, 2X SYBR green PCR Master Mix (Applied Biosystems, USA), and HPLC (J. T baker, USA) were mixed in a PCR tube to make a reaction solution, which was then run on a StepOnePlus Real-Time PCR System ( PCR was performed using Applied Biosystems, USA).
IL-1 유전자의 PCR primer 서열은 아래 표 3에 나타내었으며, 도 8은 상기 실시예에 따라서 정제된 토마토, 브로콜리 유래 엑소좀의 항염 효능을 IL-1 mRNA 발현 억제율로 평가한 결과를 나타낸 그래프이다. 시험 결과, 토마토 엑소좀, 브로콜리 엑소좀과 토마토 추출물, 브로콜리 추출물을 처리하였을 때 농도 의존적으로 염증 인자인 IL-1 mRNA가 감소하였으며 추출물 대비 엑소좀 처리 농도 범위에서 억제율이 훨씬 더 증가됨을 확인하였다. 이때 양성 대조군인 Allantoin 0.01%를 처리하였을 때는 43.1% 억제율을 보였다.The PCR primer sequences of the IL-1 gene are shown in Table 3 below, and FIG. 8 is a graph showing the results of evaluating the anti-inflammatory efficacy of exosomes derived from tomato and broccoli purified according to the above example in terms of IL-1 mRNA expression inhibition rate. . As a result of the test, it was confirmed that when the tomato exosomes, broccoli exosomes, tomato extract, and broccoli extract were treated, IL-1 mRNA, an inflammatory factor, was reduced in a concentration-dependent manner, and the inhibition rate was significantly increased in the exosome treatment concentration range compared to the extract. At this time, when Allantoin 0.01%, a positive control, was treated, 43.1% inhibition rate was shown.
시험예 10: 토마토, 브로콜리 엑소좀의 항염 효능 평가(IL-6 발현 억제)Test Example 10: Evaluation of anti-inflammatory efficacy of tomato and broccoli exosomes (inhibition of IL-6 expression)
토마토, 브로콜리 유래 엑소좀의 항염 효능을 확인하기 위해 추출물과 비교하여 IL-6 mRNA 발현 억제 시험을 진행하였다. 실험 방법은 위 시험예 9와 동일하며 IL-6 유전자의 PCR primer 서열을 아래 표 4에 나타내었다. 도 9는 상기 실시예에 따라서 정제된 토마토, 브로콜리 유래 엑소좀의 항염 효능을 IL-6 mRNA 발현 억제율로 평가한 결과를 나타낸 그래프이다. 시험 결과, 토마토 엑소좀, 브로콜리 엑소좀과 토마토 추출물, 브로콜리 추출물을 처리하였을 때 농도 의존적으로 염증 인자인 IL-6 mRNA가 감소하였으며 추출물 대비 엑소좀 처리 농도 범위에서 억제율이 훨씬 더 증가됨을 확인하였다. 이때 양성 대조군인 Allantoin 0.01%를 처리하였을 때는 46.8% 억제율을 보였다.In order to confirm the anti-inflammatory efficacy of tomato and broccoli-derived exosomes, an IL-6 mRNA expression inhibition test was performed in comparison with the extracts. The experimental method is the same as in Test Example 9 above, and the PCR primer sequence of the IL-6 gene is shown in Table 4 below. 9 is a graph showing the results obtained by evaluating the anti-inflammatory efficacy of tomato and broccoli-derived exosomes purified according to the above example in terms of IL-6 mRNA expression inhibition rate. As a result of the test, it was confirmed that when tomato exosomes, broccoli exosomes, tomato extract, and broccoli extract were treated, IL-6 mRNA, an inflammatory factor, was reduced in a concentration-dependent manner, and the inhibition rate was significantly increased in the concentration range of exosome treatment compared to the extract. At this time, when Allantoin 0.01%, a positive control, was treated, 46.8% inhibition rate was shown.
제형예 1: 크림의 제조Formulation Example 1: Preparation of Cream
하기 표 5의 조성으로 상기 실시예에 따라서 정제된 토마토 엑소좀, 브로콜리 엑소좀을 포함하는 크림을 통상의 방법으로 제조하였다. 비교예 1의 토마토 추출물을 함유하는 크림을 비교 제형예 1로 하고 비교예 2의 브로콜리 추출물을 함유하는 크림을 비교 제형예 2로 하였다.With the composition shown in Table 5 below, a cream containing purified tomato exosomes and broccoli exosomes according to the above example was prepared by a conventional method. The cream containing the tomato extract of Comparative Example 1 was used as Comparative Formulation Example 1, and the cream containing the broccoli extract of Comparative Example 2 was used as Comparative Formulation Example 2.
시험예 11: 토마토, 브로콜리 엑소좀의 피부진정 효능 평가Test Example 11: Evaluation of skin soothing efficacy of tomato and broccoli exosomes
피부 알레르기 증상이 없는 건강한 성인 남녀 20명을 대상으로 세 그룹으로 나누어 테이프 스트리핑 법(테이프를 붙였다 떼 피부에 자극을 주는 방법)을 통한 피부진정 효능을 평가하였다. 테이프를 사용하여 하박 내측에 피부 자극 및 홍반을 유발한 후 상기 제형예에서 제조한 크림을 일정량 도포하여 3시간 후에 자극이 진정되는 정도를 확인하였다. 그 결과를 하기 표 6에 나타내었다.Twenty healthy adult men and women without skin allergy symptoms were divided into three groups and the skin soothing effect was evaluated through the tape stripping method (a method of stimulating the skin after attaching the tape). After inducing skin irritation and erythema on the inside of the habak using a tape, a certain amount of the cream prepared in the above formulation was applied to confirm the degree to which the irritation subsided after 3 hours. The results are shown in Table 6 below.
(-; 홍반없음, +; 매우 경미한 홍반, ++; 희미한 홍반, +++; 뚜렷한 홍반, ++++; 심한 홍반)(-; no erythema, +; very mild erythema, ++; faint erythema, +++; marked erythema, ++++; severe erythema)
상기 표 6의 결과에서도 알 수 있듯이, 본 발명의 토마토 엑소좀, 브로콜리 엑소좀, 토마토, 브로콜리 혼합 엑소좀이 포함된 크림에서 우수한 피부진정 효과를 나타내었다.As can be seen from the results of Table 6, the cream containing the tomato exosome, broccoli exosome, and tomato/broccoli mixed exosome of the present invention showed excellent skin soothing effect.
시험예 12: 모발 성장 촉진 효능 평가(모유두세포 증식)Test Example 12: Evaluation of hair growth promoting efficacy (hair papilla cell proliferation)
토마토, 브로콜리 유래 엑소좀의 모발 성장 촉진 효능을 확인하기 위해 농도 별 토마토, 브로콜리 추출물과 비교하여 모유두세포 증식에 미치는 영향을 확인하였다. 모낭을 구성하는 모유두세포인 HGDPC 세포주(Human follicle dermal papilla cell)를 96 well plate에 1×104 cells/mL로 분주하여 배양한 후 토마토 엑소좀, 브로콜리 엑소좀, 그 혼합 엑소좀과 토마토 추출물, 브로콜리 추출물 및 DHT(5α-dihydrotestosterone)를 10μM이 되도록 처리하여 48시간 배양하였다. 배양 후 10x BrdU solution을 처리하여 6시간 배양한 뒤 solution을 제거하고 Anti-BrdU Antibody를 처리하여 상온에서 1시간 동안 반응시켰다. Secondary Antibody HRP Conjugate를 첨가하여 반응시킨 뒤 PBS 로 세척 후 substrate solution을 넣어 반응시키고 stop solution을 이용하여 반응을 종료시킨 뒤 450nm에서 흡광도를 측정하였다.In order to confirm the hair growth promoting effect of tomato and broccoli-derived exosomes, the effect on dermal papilla cell proliferation was confirmed by comparing with tomato and broccoli extracts at each concentration. HGDPC cell line (Human follicle dermal papilla cell), which is a dermal papilla cell constituting hair follicles, was divided into 1×10 4 cells/mL in a 96 well plate and cultured, and then tomato exosomes, broccoli exosomes, the mixed exosomes and tomato extract, Broccoli extract and DHT (5α-dihydrotestosterone) were treated to be 10 μM and cultured for 48 hours. After incubation, the cells were treated with 10x BrdU solution and incubated for 6 hours, then the solution was removed, treated with Anti-BrdU Antibody, and allowed to react at room temperature for 1 hour. Secondary Antibody HRP Conjugate was added and reacted, washed with PBS, reacted with substrate solution, and the reaction was terminated using stop solution, and absorbance was measured at 450 nm.
도 10은 각 시료의 모발 성장 촉진 효능을 모유두세포 증식 효과로 평가한 결과를 나타낸 그래프이다. 시험 결과, 토마토, 브로콜리 유래 엑소좀과 토마토, 브로콜리 추출물을 처리하였을 때 농도 의존적으로 세포 증식이 증가하였으며 추출물에 비해 토마토, 브로콜리 유래 엑소좀을 처리하였을 때 증식이 더 증가됨을 확인하였다. 역시 토마토와 브로콜리 혼합 엑소좀을 처리하였을 때 가장 높은 세포 증식율을 보였으며 이 때 양성 대조군인 Minoxidil 10Μm을 처리하였을 때는 90.7% 증식율을 보였다.10 is a graph showing the results of evaluating the hair growth promoting effect of each sample as the dermal papilla cell proliferation effect. As a result of the test, it was confirmed that the cell proliferation was increased in a concentration-dependent manner when the tomato and broccoli-derived exosomes were treated with the tomato and broccoli extracts, and the proliferation was further increased when the tomato and broccoli-derived exosomes were treated compared to the extracts. Also, the highest cell proliferation rate was shown when the tomato and broccoli mixed exosomes were treated, and at this time, when the positive control, Minoxidil 10Μm, was treated, the proliferation rate was 90.7%.
시험예 13: 탈모방지 효능 평가 (5알파-환원효소(5α-reductase)활성 저해)Test Example 13: Evaluation of anti-hair loss efficacy (inhibition of 5α-reductase activity)
토마토, 브로콜리 유래 엑소좀의 탈모방지 효능을 확인하기 위해 농도 별 토마토, 브로콜리 추출물과 비교하여 5알파-환원효소(5α-reductase)저해 활성에 미치는 영향을 확인하였다. 모낭을 구성하는 모유두세포인 HGDPC 세포주(Human follicle dermal papilla cell)를 24 well plate에 4×105 cells/mL로 분주하여 24시간 배양한 후 토마토, 브로콜리 엑소좀과 토마토, 브로콜리 추출물을 처리하여 1시간 배양하였다. 배양 후 테스토스테론(testosterone)을 처리하였으며 상등액을 분리하여 세포 펠렛을 수득하였다. 수득한 펠렛은 효소면역측정법을 이용하여 디하이드로테스토스테론(DHT, dihydrotestosterone)의 농도를 측정하였다. DHT ElISA Kit strip-well에 세포 펠렛을 100μl씩 분주하고 DHT 항혈청을 25μl씩 분주하여 4℃에서 약 18시간동안 반응시켰다. 반응 후 각 웰에 HRP-Streptavidin Conjugate를 100μl씩 분주하고 30분간 상온에서 반응시킨 후 세척하였다. 세척 후 TMB 기질을 90μl을 분주하고 20분 이내로 상온에서 반응시킨 후 50μl의 stop 용액을 처리하고 처리 직후 450nm에서 흡광도를 측정하여 DHT의 농도를 정량하였다. In order to confirm the anti-hair loss efficacy of tomato and broccoli-derived exosomes, the effect on 5α-reductase inhibitory activity was compared with tomato and broccoli extracts for each concentration. HGDPC cell line (Human follicle dermal papilla cell), which is a dermal papilla cell constituting hair follicles, was dispensed in a 24 well plate at 4 × 10 5 cells / mL and cultured for 24 hours. time incubated. After culturing, testosterone was treated, and the supernatant was separated to obtain a cell pellet. The obtained pellet was measured for the concentration of dihydrotestosterone (DHT) using enzyme immunoassay. DHT ElISA Kit strip-well was dispensed with 100 μl of the cell pellet and 25 μl of DHT antiserum, and reacted at 4° C. for about 18 hours. After the reaction, 100 μl of HRP-Streptavidin Conjugate was dispensed into each well, reacted at room temperature for 30 minutes, and washed. After washing, 90 μl of the TMB substrate was dispensed and reacted at room temperature within 20 minutes. Then, 50 μl of the stop solution was treated, and the absorbance was measured at 450 nm immediately after the treatment to quantify the concentration of DHT.
도 11은 각 시료의 탈모방지 효능을 알파-환원효소(5α-reductase)저해 활성 시험으로 평가한 결과를 나타낸 그래프이다. 시료를 처리하지 않은 음성 대조군을 기준으로 5알파-환원효소 억제율로 계산하였다. 시험 결과, 토마토, 브로콜리 유래 엑소좀을 처리하였을 때 농도 의존적으로 저해 활성이 증가하였다. 토마토와 브로콜리 혼합 엑소좀을 처리하였을 때 가장 우수한 저해 활성을 나타냈다.Figure 11 is a graph showing the results of evaluating the hair loss prevention efficacy of each sample by alpha-reductase (5α-reductase) inhibitory activity test. Based on the negative control group, which was not treated with the sample, the 5 alpha-reductase inhibition rate was calculated. As a result of the test, the inhibitory activity increased in a concentration-dependent manner when the tomato and broccoli-derived exosomes were treated. The best inhibitory activity was shown when tomato and broccoli mixed exosomes were treated.
시험예 14: 탈모방지 효능 평가Test Example 14: Evaluation of hair loss prevention efficacy
토마토 엑소좀(실시예 1, 실시예 4), 브로콜리 엑소좀(실시예 2, 실시예 10), 혼합 엑소좀(실시예 3)의 탈모 방지 효능을 확인하기 위해 농도 별 토마토 추출물, 브로콜리 추출물과 비교하여 초기 탈모가 진행되는 성인 30명을 대상으로 12주동안 실험을 진행하였다. 상기 실시예에 따라 정제된 토마토 유래 엑소좀, 브로콜리 유래 엑소좀과 그 혼합 엑소좀을 5% 농도로 처방하여 1일 1회 도포하고 약 20분 후 머리를 감게 하였다. 12주 후 탈락모를 수거하여 개수를 세었으며 그 결과를 아래 표 7에 나타내었다. 음성 대조군으로는 아무 것도 처리하지 않은 상태에서 탈락모를 수거하여 비교하였다.Tomato extract, broccoli extract and In comparison, an experiment was conducted for 12 weeks on 30 adults with early hair loss. Tomato-derived exosomes, broccoli-derived exosomes, and mixed exosomes purified according to the above example were prescribed at a concentration of 5% and applied once a day, and hair was washed after about 20 minutes. After 12 weeks, the fallen hairs were collected and counted, and the results are shown in Table 7 below. As a negative control group, fallen hairs were collected and compared in the state of not being treated with anything.
실험 결과, 토마토 추출물, 브로콜리 추출물에 비해 엑소좀을 처리하였을 때 탈락모의 개수가 현저히 감소하는 것을 확인하였다.As a result of the experiment, it was confirmed that the number of exfoliated hairs significantly decreased when treated with exosomes compared to tomato extract and broccoli extract.
Claims (9)
상기 유효성분으로서의 토마토 엑소좀과 브로콜리 엑소좀은,
(A)토마토 또는 브로콜리를 40~60℃, 20~24시간 열풍건조 처리하는 단계;
(B)열풍건조 처리한 토마토 또는 브로콜리를 30~40℃의 물에 6시간동안 침지하는 단계;
(C)침지시킨 토마토 또는 브로콜리에 UV-A를 1~6시간 처리하는 단계;
(D)UV 처리한 토마토 또는 브로콜리를 착즙하는 단계;
(E)상기 착즙액을 1,000xg~10,000xg에서 원심분리하여 상층액을 수득하는 단계;
(F)엑소좀이 존재하는 상기 상층액을 동결건조하는 단계;
(G)상기 동결건조물에 PEG(Polyethylene glycol)/Dextran을 사용하여 수성 2상계를 형성하는 단계; 및
(H)상기 수성 2상계 중 엑소좀이 농축된 하층액을 수득하는 단계를 포함하는 방법에 의하여 정제된 것임을 특징으로 하는 화장료 조성물.In the cosmetic composition containing tomato exosomes, broccoli exosomes or mixed exosomes as an active ingredient,
Tomato exosomes and broccoli exosomes as the active ingredient,
(A) subjecting tomatoes or broccoli to hot air drying at 40 to 60° C. for 20 to 24 hours;
(B) immersing tomatoes or broccoli treated with hot air drying in water at 30 to 40 ° C for 6 hours;
(C) UV-A treatment of immersed tomatoes or broccoli for 1 to 6 hours;
(D) squeezing UV-treated tomatoes or broccoli;
(E) obtaining a supernatant by centrifuging the juice at 1,000xg to 10,000xg;
(F) freeze-drying the supernatant in which exosomes are present;
(G) forming an aqueous two-phase system using PEG (Polyethylene glycol)/Dextran in the lyophilisate; and
(H) A cosmetic composition characterized in that it is purified by a method comprising obtaining a lower layer in which exosomes are concentrated in the aqueous two-phase system.
(B)열풍건조 처리한 토마토 또는 브로콜리를 30~40℃의 물에 6시간동안 침지하는 단계;
(C)침지시킨 토마토 또는 브로콜리에 UV-A를 1~6시간 처리하는 단계;
(D)UV 처리한 토마토 또는 브로콜리를 착즙하는 단계;
(E)상기 착즙액을 1,000xg~10,000xg에서 원심분리하여 상층액을 수득하는 단계;
(F)엑소좀이 존재하는 상기 상층액을 동결건조하는 단계;
(G)상기 동결건조물에 PEG(Polyethylene glycol)/Dextran을 사용하여 수성 2상계를 형성하는 단계; 및
(H)상기 수성 2상계 중 엑소좀이 농축된 하층액을 수득하는 단계를 포함하는 토마토 또는 브로콜리 엑소좀의 정제방법.(A) subjecting tomatoes or broccoli to hot air drying at 40 to 60° C. for 20 to 24 hours;
(B) immersing tomatoes or broccoli treated with hot air drying in water at 30 to 40 ° C for 6 hours;
(C) UV-A treatment of immersed tomatoes or broccoli for 1 to 6 hours;
(D) squeezing UV-treated tomatoes or broccoli;
(E) obtaining a supernatant by centrifuging the juice at 1,000xg to 10,000xg;
(F) freeze-drying the supernatant in which exosomes are present;
(G) forming an aqueous two-phase system using PEG (Polyethylene glycol)/Dextran in the lyophilisate; and
(H) A method for purifying tomato or broccoli exosomes comprising the step of obtaining a lower layer in which exosomes are concentrated in the aqueous two-phase system.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220121020A KR102502664B1 (en) | 2022-09-23 | 2022-09-23 | Cosmetic composition for improving skin and hair condition containing Solanum Lycopersicum(Tomato) Fruit exosome, Brassica Oleracea Italica(Broccoli) exosome |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220121020A KR102502664B1 (en) | 2022-09-23 | 2022-09-23 | Cosmetic composition for improving skin and hair condition containing Solanum Lycopersicum(Tomato) Fruit exosome, Brassica Oleracea Italica(Broccoli) exosome |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102502664B1 true KR102502664B1 (en) | 2023-02-23 |
Family
ID=85329937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220121020A KR102502664B1 (en) | 2022-09-23 | 2022-09-23 | Cosmetic composition for improving skin and hair condition containing Solanum Lycopersicum(Tomato) Fruit exosome, Brassica Oleracea Italica(Broccoli) exosome |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102502664B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116803404A (en) * | 2023-08-24 | 2023-09-26 | 汤臣倍健股份有限公司 | Application of water-soluble tomato concentrate in preparation of hair loss reducing and hair growing products |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000229828A (en) * | 1999-02-05 | 2000-08-22 | Kose Corp | Skin bleaching lotion |
KR20140022601A (en) * | 2012-08-14 | 2014-02-25 | 주식회사 오감바이오 | Natural soap and cosmetic composition comprising broccoli water extract and preparation method thereof |
KR101970144B1 (en) * | 2018-11-15 | 2019-04-18 | 주식회사 에스제이인터내셔널 | Cosmetic composition for whitening with green tomato extracts, burdock root extracts and chickpea extracts |
KR102125567B1 (en) | 2019-07-02 | 2020-06-22 | 한양대학교 에리카산학협력단 | Large-Scale Production of Plant Derived Exosomes |
KR20210018735A (en) | 2019-08-09 | 2021-02-18 | 주식회사 피에프네이처 | Compositions for Anti-Acne and Anti-Inflammatory Effect Comprising Complex Extract of Houttuynia cordata |
KR102265811B1 (en) | 2021-04-09 | 2021-06-16 | 주식회사 에이바이오머티리얼즈 | Method for isolation and purification of Centella asiatica exosome and cosmetic composition containing the same |
KR20220046417A (en) * | 2020-10-07 | 2022-04-14 | 주식회사 아스트로제네시스 | Composition for promoting hair growth and/or inhibiting hair loss |
KR102391636B1 (en) * | 2021-12-02 | 2022-04-28 | 주식회사 에이바이오머티리얼즈 | Cosmetic composition for improving skin and hair condition containing Scutellaria baicalensis exosome, Houttuynia cordata exosome |
-
2022
- 2022-09-23 KR KR1020220121020A patent/KR102502664B1/en active IP Right Grant
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000229828A (en) * | 1999-02-05 | 2000-08-22 | Kose Corp | Skin bleaching lotion |
KR20140022601A (en) * | 2012-08-14 | 2014-02-25 | 주식회사 오감바이오 | Natural soap and cosmetic composition comprising broccoli water extract and preparation method thereof |
KR101970144B1 (en) * | 2018-11-15 | 2019-04-18 | 주식회사 에스제이인터내셔널 | Cosmetic composition for whitening with green tomato extracts, burdock root extracts and chickpea extracts |
KR102125567B1 (en) | 2019-07-02 | 2020-06-22 | 한양대학교 에리카산학협력단 | Large-Scale Production of Plant Derived Exosomes |
KR20210018735A (en) | 2019-08-09 | 2021-02-18 | 주식회사 피에프네이처 | Compositions for Anti-Acne and Anti-Inflammatory Effect Comprising Complex Extract of Houttuynia cordata |
KR20220046417A (en) * | 2020-10-07 | 2022-04-14 | 주식회사 아스트로제네시스 | Composition for promoting hair growth and/or inhibiting hair loss |
KR102265811B1 (en) | 2021-04-09 | 2021-06-16 | 주식회사 에이바이오머티리얼즈 | Method for isolation and purification of Centella asiatica exosome and cosmetic composition containing the same |
KR102391636B1 (en) * | 2021-12-02 | 2022-04-28 | 주식회사 에이바이오머티리얼즈 | Cosmetic composition for improving skin and hair condition containing Scutellaria baicalensis exosome, Houttuynia cordata exosome |
Non-Patent Citations (3)
Title |
---|
약 개발에 쓰던 ‘엑소좀’화장품 시장서 주목, 한경 BIO Insight, 2019.03.18. * |
엑소좀 기술접목 병.의원 전용‘RX 바이오 엑소좀 앰플’ 출시, 의학신문, 2022.06.16. * |
홍재상 외 1명. 엑소좀의 생물학적 기능 및 치료제로서의 가능성. 생명자원연구, 23: 75-85 (2015) * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116803404A (en) * | 2023-08-24 | 2023-09-26 | 汤臣倍健股份有限公司 | Application of water-soluble tomato concentrate in preparation of hair loss reducing and hair growing products |
CN116803404B (en) * | 2023-08-24 | 2023-12-15 | 汤臣倍健股份有限公司 | Application of water-soluble tomato concentrate in preparation of hair loss reducing and hair growing products |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2506723B1 (en) | Acacia macrostachya seed extract and compositions containing same | |
EP3060228B1 (en) | Lipid extract of passion fruit seeds | |
KR101828584B1 (en) | Composition containing complex extracts including Veratrum nigrum var. ussuriense, Juglans mandshurica, Rodgersia podophylla and Chaenomeles sinensis with antioxidant activity or whitening | |
EP2506724B1 (en) | Vigna unguiculata seed extract and compositions containing the same | |
KR102391636B1 (en) | Cosmetic composition for improving skin and hair condition containing Scutellaria baicalensis exosome, Houttuynia cordata exosome | |
KR20160091301A (en) | Brassocattleya marcella koss orchid extract and use thereof as skin depigmentation agent | |
KR101861043B1 (en) | Composition for Improving Skin Wrinkles Using an Extract of Penthorum chinense | |
KR102587666B1 (en) | Cosmetic composition comprising stabilized glutathione by lipid nanoparticles and physiologically active materials | |
KR101846503B1 (en) | Composition for Preventing Hair Loss or Improving Hair Growth Hibiscus and Pawwpaw | |
KR20150050310A (en) | Composition for improving skin conditions comprising artemisiae annuae herba, neem leaf, centella asiatica and green tea extract or fraction thereof and method for improving skin conditions using the same | |
JP2021509413A (en) | Kapok tree flower extract and cosmetological, pharmaceutical or dermatological compositions containing it | |
KR102502664B1 (en) | Cosmetic composition for improving skin and hair condition containing Solanum Lycopersicum(Tomato) Fruit exosome, Brassica Oleracea Italica(Broccoli) exosome | |
KR101390465B1 (en) | Method for Preparing Paeonia lactiflora Extracts Containing Taxifolin-3-glucoside and Cosmetic Composition Containing Preparing Paeonia lactiflora Extracts | |
KR102523523B1 (en) | Cosmetic composition for improving skin and hair condition containing Nepeta Cataria exosome and Spinacia Oleracea exosome | |
KR101757469B1 (en) | Compositions for promoting hair growth and inhibiting inflammation comprising mixed extracts of natural products | |
CN110403890A (en) | The composition for beautifying skin including sturgeon Egg extracts and sturgeon amniotic fluid extract | |
KR102343705B1 (en) | Cosmetic composition containing natural complex extracts as active ingredient | |
KR102257448B1 (en) | Cosmetic composition containing black kelp | |
JP4672269B2 (en) | Anti-aging agent, platelet aggregation inhibitor, antioxidant, antiallergic agent, skin cosmetics and food and drink | |
KR102619110B1 (en) | Antioxidant, skin whitening and skin wrinkle improvement composition | |
JP5689552B1 (en) | A skin external preparation or an internal preparation containing an extract of chamomile grown by irradiating light having a specific wavelength range. | |
KR102485314B1 (en) | Cosmetic composition comprising fermented shea butter and exosome derived from lactic acid bacteria | |
KR102671639B1 (en) | Cosmetic composition containing Dendranthema zawadskii var. lucidum exosome and ginko biloba leaf exosome | |
KR102701545B1 (en) | STEAM ULTRASONIC EXTRACT COMPRISING Nardostachys jatamansi, Ocimum basilicum AND Crocus sativus, AND COMPOSITION FOR INDUCTION OF BLACK HAIR AND PREVENTING OF WHITE HAIR USING THE SAME | |
KR102528139B1 (en) | Cosmetic composition containing Camellia Sinensis Leaf exosome and Avena Sativa(Oat) Kernel exosome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |